Bis-1,3-diazine Heterocyclic Derivatives as Antiarrhythmic Agents by Berlin, Kenneth Darrell et al.
United States Patent [19J 
Berlin et al. 
[54] BIS-1,3-DIAZINE HETEROCYCLIC 
DERIVATIVES AS A'.\TIARRHYTH~UC 
AGENTS 
[75] Inventors: Kenneth D. Berlin; Mark D. 
Thompson, both of Stillwater; 
Benjamin J. Scherlag, Oklahoma 
City; Gary S. Smith, Stillwater, all of 
Okla. 
[73] Assignee: Oklahoma State University, 
Stillwater, Okla. 
[21] Appl. No.: 596,550 
[22] Filed: Nov. 15, 1990 
Related U.S. Application Data 
[62] Division of Ser. No. 448,658. Dec. 11. 1989, Pat. No. 
4,980,468. 
[I I] Patent Number: 
[45] Date of Patent: 
5,043,445 
Aug. 27, 1991 
(51] Int. CJ.5 .................. C07D 401/14; C07D 409/14: 
C07D 421/14; C07D 407/14 
[52] U.S. Cl. .................................................... 544/231 
(58] Field of Search ......................................... 544/231 
[56] References Cited 
U.S. PATENT DOCUMENTS 
4,581.361 4/1986 Berlin et al. ....................... 514/301 
Primary Examiner-Mary C. Lee 
Assistant Examiner-Lenora '.\1iltenberger 
Attorney, Agent, or Firm-Head & Johnson 
[57] ABSTRACT 
3-7-Diheterabicylo[3.3. l]nonanes and derivati\'es 
thereof are disclosed. Their method of preparation and 
use as antiarrhythmic agents is given. 
8 Claims, ::-,;o Drawings 
5,043,445 
1 
BIS-1,3-DIAZil"i'E HETEROCYCLIC DERIVATIVES 
AS ANTIARRHYTH'.\HC AGENTS 
This is a divisional of copendir.g application Ser. No. 5 
07/448,658 filed on Dec. 11, 1989, now U.S. Pat. No. 
4,980,468. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
This invention relates to antiarrhythmic composi-
tions. More specifically, the invention relates to certain 
3-7-diheterabicyclo(3.3. l]nonanes and derivatives 
thereof. 
2. Description of the Prior Art 
10 
15 
2 
s ::::::7 ~ K ,~, 
~ Ar 
0 
where Ar is: 
-0-0-CH,-o 
-CH,OOCH;" -CH,-QOCH; 
OCH, 
(1) 
3-azabicyclo[3.3. l]nonanes, including bicyclic sys-
tems with one heteroatom such as N, S and O and vari-
ous derivatives, are known and are documented in the 
chemical literature. In a Chemical Reviews article, 
1981, Vol. 81, No. 2, pages 149-174, entitled "Chemis- 20 
try of 3-Azabicyclo[3.3.1.]nonanes" by R. Jeyaraman 
and S. Avila the synthesis, stereochemistry, and reac-
tions of such compounds are reviewed. This article 
acknowledges the close resemblance of aza- and 
diazaadamantanes in conformation and stereochemistry 
The present invention also provides novel 3-selena-7-
azabicyclo[3.3. I]nonane compounds having the for-
25 mula: 
to the 3-azabicyclo[3.3. l.]nonanes as a cause for signifi-
cant progress in the azabicyclonane (ABN) studies. The 
article further acknowledges the ease of formation of 
3-ABNs from simple ketones and aldehydes through the 30 Mannich reaction without the involvement of compli-
cated reaction conditions and reagents and the ready 
availability of a reactive carbonyl group in most of the 
ABNs prepared as important reasons for widespread 
studies on ABNs. 35 
According to the existing chemical literature, some 
derivatives of 3-ABN have been found to possess useful 
biological activities. The observed biological activies 
have included potent analgesic properties and antitusive 
activities as well as antagonism to analgesic effects and 40 
even weak narcotic antagonism depending on the par-
ticular compound involved. Some have displayed local 
anesthetic activity and simple 3-ABN is reportedly ef-
fective against influenza infection. Other derivatives of 
3-ABN have displayed powerful ganglioplegic and 45 
hypotensive properties. Several have been found to be 
sedatives, antipyretics, and psycholaleptic and hypogly-
cemic agents. Some 3,7-diazabicyclo[3.3.l]nonanes pos-
sess antiarrhythmic potencies. 
The Chemical Reviews article further described the 50 
subclass of 3-thia-7-azabicyclo[3.3. l]nonanes as being of 
much less interest and identifies a series of diphenyl 
and/or diaryl substituted derivatives as having been 
prepared through the Mannich reaction. In U.S. Pat. 
No. 4,581,361 certain 3-thia-7-azabicyclo[3.3. l]nonanes 55 
and derivatives are disclosed and claimed as antiar-
rhythmic compounds. 
SUMMARY OF THE INVENTION 
The present invention involves novel 3, 7- 60 
diheterabicyclo[3.3. l]nonanes containing more than 
one heteroatom such as Se, N, Sand 0. In particular the 
invention involves novel 3-selena-7-azabicyclo[3.3. l-
]nonanes, corresponding nitrogen compounds, related 
polyheterotricyclo compounds and derivatives thereof. 65 
Thus the present invention provides novel 3-selena-7-
azabicyclo[3.3. l]nonan-9-one compounds having the 
formula: 
(2) 
where Ar is: 
The invention further provides the hydroperchlorate, 
HCI, HBr and HI salts of the novel nonane compot,mds 
(2) and correspond salts of the 9-diol and 9-dimethoxy 
derivatives of the selena nonanes· and methyl phenyl-
amine nonanes characterized by the formula: 
h r~ ~, y Ar y 
(3) 
x-
where Ar is: 
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-continued 
-CH,-OOCH; oc -CH,-Q-OCH; 
OCH3 
Z is Se, Sor 
NCH;-0• 
Y=-H, -OH or -OCH3 and Xis CI04-, CJ-, Br-
or I-. 
-continued 
Ar H I - x- (9) 
5 y~: 
y 
10 where Ar is Ph (i.e., 
15 
CH2Ph,p-H3C06H4CH2, 3,4-(H3C0)2C6H2CH2, o-
CIC6H4, or p-CIC6H4; X- is CI04 - , CI-, Br-, or I-; 
2o Z is Se, S, 0, or NCH2Ph; and Y is H, OH, or OCH3. 
In a similar manner the invention provides the 6,8-
diaryl substituted, selenium and nitrogen 3, 7-
diheterabicyclo[3.3. l]nonanes including the 9-one, 9-
diol and 9-dimethoxy derivatives as well as the corre- 25 
sponding acid salts characterized by the formulae: 
The invention still further provides for related 
polyheterotricyclo compounds and corresponding de-
rivatives thereof characterized by the formulae: 
( 10) 
Ar 
Ar 
0 ~ 
Ar 
HN :::::7 
y);:;, 
y 
H 
x- ~1 
Ar 
Ar 
HN :::::7 
y);:;, 
y 
(4) 
30 
OR 
cAr x- (11) 
35 
(5) 
t_ H.I ~~-/ :S-H 
:-.; z 
f,,, 0 
40 OR 
Ar o Ar \\~/! ( 12) 
(6) 45 Ar" l j ..,.Ar 
z 
(7) 
(8) 
where Ar is Ph, CH2Ph, o-H3CC6H4, p-H3CC6H4, o-
H3COC6H4, p-H3COC6H4, o-CIC6H4, or p-CIC6H4; 
50 X- is CI04-, CJ-, Br-, or I-; Z is Se, S, 0, CHR or 
NR'; R is CH3, C2Hs, n-C3H7 or i-CJHi; and R' is H, 
CH3, C2Hs or C(CH3)3. 
More specifically the invention relates to the 3-
selena-7-azabicyclo[3.3. l]nonane compounds and their 
55 respective hydroperchlorate salts as used in an antiar-
rhythmic process. 
Thus, it is an object of the present invention to pro-
vide novel compositions that display biological activity. 
Fulfillment of this object and the presence and fulfill-
60 ment of other objects will be apparent upon complete 
reading of the specification and claims. 
65 
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
The chemical compositions according to the pre-
ferred embodiments of the present invention are 
heteronuclear ring organic compounds based on the 
3, 7-diheterabicyclo[3.3. l]nonane structure as follows: 
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~4 KR} N\ 
~ Ar 
O 9 6 
(13) 
5 
(1 4) 10 
(15) 15 
20 
(16) 
25 
Wherein the 3-position of the 9-one structure for 
formula (13) is selenium, but includes oxygen, nitrogen 30 
as well as selenium in the other formulae (14), (15), and 
(16) and also sulfur in the 9-disubstituted of formula 
(16). The 7-position is an alkylated nitrogen atoms (aryl 
substituted tertiary amine) and includes the acid amine 35 
salts such as the perchlorate and halogen acid salts, 
preferably the hydroperchlorate salt. The disubstituted 
9-position of the formula (16) is preferably either a 9-
diol or 9-dialkyloxy structure. 
The novel chemical compositions according to the 40 
preferred embodiments of the present invention also 
include the 6,8-diaryl substituted 3,7-diheterabicy-
clo[3.3. l]nonane structures as follows: 
45 
Ar (4) 
HN 
'7 };;z 
0 
50 
Ar (5) 
55 
60 
Ar 
x-
-continued 
Ar 
yfi;: 
y 
H 
.,., Ar 
HN Y:kz 
y 
(7) 
(8) 
(9) 
In these 6.8-diaryl substituted derivatives, the 3-posi-
tion is preferably selenium, sulfur, nitrogen. oxygen and 
carbon and includes the endo-endo and endo-exo iso-
mers. As in the previous formulae (13) through (16), the 
9-position can be preferably unbsubstituted. 9-one. 9-
diol or 9,9-dimethoxy and also includes the alkylated 
nitrogen atom at the 7-position and their corresponding 
tertiary amine acid salts (hydroperchlorate, HCl, HBr 
and HI). 
The novel chemical compositions according to the 
preferred embodiments of the present invention further 
includes the related polyheteratricyclo compounds 
based on the following structural formulae: 
( 10) 
(11) 
Ar O Ar \ I 
~~N~II N:: 
' ~ Ar Ar 
(12) 
z 
(6) 
In these tricycle compounds, the hetero atoms in-
clude selenium, sulfur, oxygen and nitrogen along with 
either two or four alkylated nitrogen atoms as well as a 
65 tertiary amine acid salts (preferably the hydroperchlo-
rate). 
These compounds are the active ingred;ents for po-
tential drugs and/or intermediates for the 3.ctive ingre-
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dients of potential drugs for use in the treatment of 
disorders of the heart. They display good antiarrhyth-
mic activity and as such are viable candidates to control 
arrhythmias in humans who have suffered heart attacks 
or infarctions. 5 
Typically, the 9-one and the tricyclo ether oxygen 
and ketone containing compounds are synthesized by 
the reaction of a tetrahydroheterapyranone in the pres-
ents of an aldehyde and amine or ammonium salt ac- IO 
cording to a Mannich or Mannich-type reaction. For 
example, and as illustrated in the following reaction 
scheme A, 4-selenanone ( 17) is typically reacted with an 
amine such as benzylamine, 2-aminomethylthiophene, 
phenethylamine, p-methoxyphenethylamine, 3,4-dime- 15 
thoxyphenethylamine and the like and paraformalde-
hyde in the presence of glacial acetic acid and methanol 
to produce the 3-selena-7-azabicyclo(3.3. J]nonane-
9-ones (18). The 9-one (18) is then either reduced with 20 
hydrazine hydrate in triethylene glycol/potassium hy-
droxide media and then reacted directly with perchloric 
acid in benzene yielding the hydroperchlorate of 3-
selena-7-azabicyclo(3.3. J]nonanes (I 9) or the corre-
sponding 9,9-diol derivatives (20) respectively. 25 
REACTION SCHE:vfE A 
0 o, 0 (17) 
Se 
l ArCH2NH2 H2C = 0 HOAc/H3COH 
Se ::::::-7 . 
(2) ;:__ ~(~~ 
0 
~ Ar 
30 
35 
40 
45 
drate followed by conversion to the secondary amine 
salt (24); i.e., hydroperchlorate in this embodiment.· 
HN 
REACTION SCHEME B 
0 
n 
Se 
Ar 
Ar 
~~r . NH r 
~Se 
O (21) 
..... Se 
.
0 (22l 
HN 
Ar 
~Ar 
~Se 
(24) 
Reaction scheme C using J-benzyl-4-piperidone (25) 
in a manner closely analogous to the previous reactions 
scheme A which used 4-selenanone as a reactant. As 
illustrated, the aryl amine (again benzylamine) and para-
formaldehyde react in the presence of glacial acetic acid 
and methanol to produce the N,N'-dibenzyl-3,7-
diazabicyclo(3.3. J)nonan-9-one (26). This diazabicy-
(19) 55 clo(3.3. l]nonan-9-one (26) is then converted to one of 
In reaction scheme B, the tetrahydroheterapyranone 
is reacted with an aldehyde in absolute ethanol and 
ammonium acetate to produce a mixture of 6,8-aryl 
substituted 3, 7-diheterabicyclo(3.3. l)nonan-9-one iso-
mers. As specifically illustrated in scheme B using 4-
selenanone (17) as the reactant, a mixture of 6,8-diaryl-
3-selena-7-azabicyclo )3. 3 .1 ]nonan-9-one isomers (21) 
and (22) are synthesized. As further illustrated and after 
isolation, the isomer is converted sequentially to the 
corresponding 6,8-diaryl-3-selena-7-azabicyclo(3.3. l-
]nonane (23) using the reducing agent hydrazine hy-
three derivatives by one of three separate reaction path-
ways. Using perchloric acid in benzene and 3 A molecu-
lar sieve with methanol, the hydroperchlorate amine 
salt of the 9,9-dimethoxy derivative (27) is produced. 
60 The use of perchloric acid in an aqueous media pro-
duces the hydraperchlorate amine salt of the 9,9-dihy-
droxy derivative (28). And, in a manner analogous to 
the reaction scheme A, a sequential reduction using 
65 hydrazine hydrate in triethylene glycol and potassium 
hydroxide followed by perchloric acid in benzene pro-
duces the hydroperchlorate tertiary amine salt of the 
reduced form of the diazabicyclo(3.3. l]nonane (29). 
9 
REACT!O'\ SCHE\IE C 
0 
0 
'\ 
Ph) 
(25) 
I '.'hCH,,H,iH.:C=O t H.1CCOOH/H1COH 
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Ph. Ph 
10 
:-,;) ;:·~I. CIOo 
HCI0 •. 1H•O 
'~ -c--,-~-n-,,-H-~-12-~-H-O-H->• '\ 
I HO l'h 
0 r Ph (261 OH 12~1 
H 1COH/HCIC1/.i 
Cnfh 
mnkL"t1lar \It:\~ 3.-\ 
l'h 
,)/ CIO, 
'\ 
!-11CO Ph 
OCH, 
127) 
2'\'\H,.H:O 
EG, KOH 
21 !-ICI0,11C,.H,, 
In reaction scheme D, the l-benzyl-4-piperidone (25) .. o 
of scheme C is reacted with an aromatic aldehyde (or-
tho-chlorobenzaldehyde in this specifically illustrated 
embodiment) with ammonium acetate and absolute eth-
anol in a manner similar to scheme B. An isomeric mix- .. ~ 
ture of the 6,8-ortho-chlorobenzyl derivatives of 3,7- · 
diazabicyclo[3.3. l)nonan-9-one (30) and (31) are pro-
duced. As further illustrated and with isomeric isola-
tion, the 9-ones (30) and (31) are converted to the corre-
sponding 6,8-bi(ortho-chlorophenyl) diazabicy- 50 
clo[3.3. l)nonane (32) and (33) by the reducing agent 
hydrazine hydrate. This in turn can be converted to the 
isomeric mixture of the corresponding tertiary amine 
acid salts; i.e., hydroperchlorate salts in this illustrate 
(34) and (35). 55 
REACTIO:-.i SCHD!E B 
0 
0 (25) 60 
'\ ) 
Ph I n-CIC0 H-1CHO 
• t H.1COO'\!-l,1/C,HsO!-l 65 
H'\ 
-continued 
RL\CTl(J'\ ~CHE\IE ll 
0-CIC,,Ha <_l·CIC,.HJ 
0-CIC,,Hs 
j .~ _I ) t HCIOc C II 
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2-CIC6H4 
11 
-continued 
REACTION SCHEME B 
,i-CIC6H4 
HN 
'1 t" 1:~•"· 1~6'4 J ... CIO4- J ... CIO4-N\ + N\ 
Ph Ph 
(34) (35) 
In the closely related reaction scheme E, the generic 
starting tetrahydroheterapyranone (36) is reacted with 
an amine (benzylamine as illustrated) and paraformalde-
hyde in glacial acetic acid and methanol. A resulting 
mixture of the dispiro[5. l.5.3]hexadecan-7-one (37) and 
the pyrido[3,4-e]-l,3-oxazine (38) are produced. As 
further suggested and after isolation the corresponding 
tertiary amine acid salts (the hydroperchlorate salt (39) 
in this illustrated embodiment) can be produced by the 
action of perchloric acid in benzene and isopropyl alco-
hol. 
REACTION SCHEME E 
0 
n 
:-.; 
(36) 
I :hCH2:--:H2/H2C=O 
{H3COOH/H3COH 
/Ph 
N Ph 
l_N Z 
j,,, 0 
OCH3 
(37) 
reaction schemes. Similarly, various appropriate re_ac-
tants can be employed in the selective oxidation or 
reduction at the 9-position as generally knO\vn in the 
art. The Mannich reaction is particularly useful in that, 
5 as previously indicated, it does not required compli-
cated reaction conditions and reagents. However for 
purposes of the present invention, other methods of 
synthesis well known in the art should be considered 
equivalent. For example and for more detailed disclo-
10 sure of various alternative methods of synthesis (includ-
ing the Mannich reaction) and methods of synthesis of 
various subsequent derivatives, the previously men-
tioned Chemical Reviews article by Jeyaraman et al. is 
again cited and herein incorporated by reference for 
15 such purposes. Furthermore, according to the preferred 
embodiments of the present invention, the water solu-
bility of the 3, 7-hetrabicyclo[3.3. l]nonane compounds 
and related heteratricyclo compounds can be advanta-
geously enhanced by formation of the corresponding 
20 tertiary amine salts and the like, prior to patient treat-. 
ment. 
In order to further illustrate -the formation of the 
3,7-diheterabicyclo[3.3. l]nonanes and related com-
pounds according to the present invention, the prepara-
Ph0~, w r;/h 
IN :-.;\ . 
Ph Ph 
HClO4/C6H6 
{H3C)zCHOH 
/Ph 
Ph H ~'\.H CI04-
\_ I + N Z 
j,,, 0 
OCH3 
(39) 
z 
(38) 
It should be appreciated that other tetrahy-
droheterapyranones, arylamines and aromatic alde-
hydes can readily be selected a1s reactants for the Man-
nich or Mannich-type reactions being illustrated in the 
tion and isolation of purified, water soluble, biological-
ly-active tertiary and secondary amine salts thereof and 
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the antiarrhythmic activity of the compositions the 
following sequence of examples are presented. 
EXAMPLE I 
7-Benzyl-3-selena-7-azabicyclo(3.3. l]nonan-9-one (40) 5 
Benzylamine (0.67 g, 6.26 mmol) and glacial acetic 
acid (0.38 g, 6.33 mmol) were dissolved in dry methanol 
(30 mL). Paraformaldehyde (1.5 g, 50 mmol) was added 
and the resulting mixture was brought to reflux under 
an atmosphere of nitrogen. 4-Selenanone (1.00 g, 6.13 IO 
mmol) was then added in one portion which quickly 
turned the solution yellow. Boiling was continued 
under nitrogen in the dark for 5 hours. The resulting 
deep red solution was then allowed to cool to room 
temperature and was stirred for an additional 18 hours. 15 
The methanol was evaporated (aspirator) and the 
orange residual oil was partitioned between ether (50 
mL) and water (50 mL). The ether layer was discarded 
and the aqueous layer was made basic with KOH (85%, 
1.2 g 18.2 mmol). This solution was extracted with ether 20 
(5 X 40 mL). The combined extracts were dried 
(K2CO3) and evaporated (aspirator) to give an oil 
which was digested on a steam bath with Skelly B (50 
mL). Evaporation gave a light yellow oil which solidi-
fied upon standing. This solid was recrystallized (95% 25 
ethanol) to give 7-benzyl-3-selena-7-azabicyclo(3.3.1-
]nonan-9-one (0.78 g, 43%) as white needles: mp 
91°-92° C.; IR (KBr) cm-11726 (C=O);lH NMR 
(DCCIJ) 82.71 [m, 4H, H(l,5),H(6.8)ax], 3.08 [m, 2H, 
H(6,8)], 3.20 [m, 4H, H(2,4)], 3.57 [s, 2H, H(l 1- 30 
ArCH2)], 7.32 [m, SH, ArH]; 13C NMR (DCCl3) ppm 
25.5 Tt, C(2,4)], 46.2 [d, C(l,5)], 59.0 (t, C(6,8)], 6!.5[t, 
C(ll-ArCH2)], 127.1 [d, C(4')], 128.2 (d) and 128.6 (d) 
[C(2',3',5',6')], 138.0 [s, C(l')], 213.8 [s, C(9)]; 15N NMR 
(DCCl3) ppm 38.31 [N(7)]; 77Se NMR (DCCl3) ppm 35 
84.68 [Se(3)]. A satisfactory elemental analysis proved 
very difficult for the compound and thus it was con-
verted to the hydroperchlorate salt without further 
purification. 
ether gave a brown oil which was digested in boiling 
Skelly B (3X JOO mL). Evaporation of the Skelly B 
gave 1.72 g of 7-benzyl-3-selena-7-azabicyclo[3.3. l ]no-
nan-9-one as a colorless viscous oil (47%): IR (film) 
cm-I 1710 (C=O); lH NMR (CDCl3) 82.60-2.74 [m, 
4H, H(2,4)], 3.02-3.18 [m, 4H, H(l,5), H(6,8)ax], 3.27 
[dd, 2H, H(6,8)eq, J = 11. 7 Hz, 3.4 Hz], 3. 75 [s. 2H, 
H(IO)], 6.0-7.30 [m, 3H, ArH]; 13C NMR (CDCl3) ppm 
24.8 [C(2,4)], 46.0 [C(l,5)], 55.6 [C(I0)], 58.5 [C(6.8)], 
124.9 (C(4')], 125.5 [C(2')], 126.1 [C(3')], 141.4 [C(l')], 
212.9 [C(9)]; 15N NMR (CDC'3) ppm 40.31 [N(7)]; 77 Se 
NMR (CDCL3) ppm 86.28 [Se(3)]. The compound was 
used without further purification. 
(41) 
EXAMPLE III 
7-Phenethyl-3-selena-7-azabicyclo[3.3. J]nonan-9-one 
(42) 
A sodium was made of phenethylamine (1.48 g. 12.3 
mmol) and glacial acetic acid (0.85 g, 14.2 mmol) in 
methanol (60 mL). Paraformaldehyde (3.0 g, 100 mmol) 
was added and the resulting mixture was heated to 
reflux with magnetic stirring under an atmosphere of. 
nitrogen. 4-Selenanone (2.00 g, 12.3 mmol) was added 
and boiling was continued for 5 hours resulting in an 
(40) 
orange solution. Methanol was evaporated (aspirator) 
and the residual orange oil was mixed with water (200 
mL). This aqueous mixture was made basic by addition 
40 
of NaOH (2.0 g, 50 mmol) and was then extract with 
ether (5 X 40 mL). The combined extracts were washed 
with saturated brine and dried (K2CO3). Evaporation 
(aspirator) gave a brown residue which was digested in 
EXAMPLE II 
45 boiling Skelly B (150) mL). Evaporation of the Skelly B 
(150 mL). Evaporation of the Skelly B gave a solid 
which was recrystallized (ethanol) to give 0.82 g (22%) 
of 7-phenethyl-3-selena-7-azabicyclo[3.3. l]nonan-9-one 
7-(2-Thiophene )methy 1-3-selena-7-azabicyclo[3.3. J ]no- 50 
nan-9-one (41) 
A solution was made of 2-aminomethylthiophene 
(1.39 g, 12.3 mmol) and glacial acetic acid (I. 10 g, 18.3 
mmol) in methanol (60 mL) in a 150 mL, three-necked, 
round-bottomed flask equipped with a water-cooled 55 
condenser. To this solution was added paraformalde-
hyde (3.0 g, 100 mmol) and the resulting mixture was 
heated to reflux. 4-Selenanone (2.00 g, 12.3 mmol) was 
added and reflux was continued for 5 hours. After al-
lowing the resulting red solution to cool to room tern- 60 
perature, the methanol was evaporated (aspirator) to 
give a red oil. This oil was partitioned between water 
and ether (100 mL: 30 mL). The ether portion was 
discarded and the aqueous layer was made basic by the 
addition of NaOH (1.5 g, 37.5 mmol). The resulting 65 
yellow suspension was extracted with ether (5 x 40 
mL). The combined extracts were washed with water 
(2 X 30 mL) and dried (K2CO3). Evaporation of the 
as a light tan solid: mp 91 '-92" C.; IR (KBr) cm- 1 1_710 
(C=O); 1H NMR (DCC)J 8262-2.83 [m, SH, 
H(2,4, 1,5, !0-ArCH2)], 3.02-3.20 [m, 6H, H(6,8, l l-
NC!:!_2)], 7.16-7.38 [m, SH, Ar-H]; I3C NMR (DCCl3) 
ppm 25.4 [5, C(2,4)], 33.7 [5, C(lO-ArCH2)], 46.2 [d, 
C(l,5)], 58.3 (5, C(l l-NCH2)], 59.1 [t, C(6,8)], 125.8 [s, 
C(4')], 128.1 [d, C(2',6') or C(3',5')], 128.4 [d, C(3',5') or 
C(2',6')], 139.7 [s, C(l')], 213.5 [s, C(9)]; 15N NMR 
(DCCl3) ppm 35.44 [N(7)]; 77Se NMR (DCCl3) ppm 
79.51 [Se(3)]. The compound was converted to the 
hydroperchlorate salt without further purification. 
(42) 
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EXAMPLE IV 
7-p-Methoxyphenethyl-3-selena-7-azabicyclo(3.3. l ]no-
nan-9-one ( 43) 
fication the compound was converted to the hydroper-
chlorate salt. · 
EXAMPLE VI 
7-Benzyl-3-selena-7-azabicyclo[3.3. l]nonane 
Hydroperchlorate (45) 
(4-1) 
A solution was made of 7-benzyl-3-selena-7-azabicy-
clo(3.3. l]nonan-9-one (2.0 g, 6.8 mmol) and hydrazine 
(95%, 5.0 g, 148 mmol) in triethylene glycol (40 mL). 
Potassium hydroxide (85%, 10.0 g, 152 mmol) was· 
added and the resulting mixture was heated to 140° C. in 
an oil bath under a nitrogen atmosphere for 12 hours. 
After cooling to room temperature. the solution was 
poured into water (200 mL) and the resulting suspen-
sion was extracted with ether (5 X 40 mL). The com-
bined extracts were dried overnight (K2CO3) and 
cooled to 0° C. Perchloric acid (60%, 2.0 g, 11.9 mmol) 
was added dropwise. The yellow orange solid which· 
A solution was made of p-methoxyphenethylamine 5 
(0.93 g, 6.16 mmol) and glacial acetic acid (0.50 g, 8.33 
mmol) in methanol (40 mL). Paraformaldehyde (1.50 g, 
50.0 mmol) was added and the resulting mixture was 
heated to reflux under an atmosphere of nitrogen. 4-
Selenanone 10 (1.00 g, 613 mmol) was added in one 10 
portion and boiling was continued for 4 hours. The 
methanol was evaporated (aspirator) from the resulting 
orange solution to give a very viscous red oil. This oil 
was dissolved in water (150 mL) and KOH (85%, 1.0 g, 
15.2 mmol) was added to make the solution very basic. 15 
The resulting yellow suspension was extracted with 
ether (5 X 40 mL). The combined extracts were washed 
with water 930 mL) and dried (K2CO3). Evaporator of 
the ether (aspirator) gave 0.72 g (35%) 7-p-methoxy-
phenethyl-3-selena-7-azabicyclo[3.3. l]nonan-9-one as a 20 
light yellow oil: IR (neat) cm- 1 1723 (C==O); 1 H NMR 
(DCCl3) 82.50-2.80 [m, SH, H(l,5,2,4, lO-ArCH2)], 
2.96-3.14 [m, 6H, H(6,8,l 1, NCH2)], 3.71 [s, 3H, OCff}], 
6.72-6.90 [m, 2H, H(3',5')], 7.00:7.16 [m, 2H, H(2',6')]; 
13C NMR (DCCl3) ppm 24.6 [C(2,4)], 32.0 [C(lO- 25 
ArCH2)], 45.4 [C(2',6')], 130.9 [C(l')], 156.9 [C(4')], 
212.5 [C(9)]; 15N NMR (DCCl3) ppm 35.43 (N(7)]; 77Se 
NMR (DCCl3) [Se(3)] ppm 78.81. Without further puri-
fication the compound was converted to the hydroper-
chlorate salt. 30 formed was filtered and recrystallized (methanol) to 
give 7-benzyl-3-selena-7-azabicyclo[3.3. l]nonane hy-· 
droperchlorate ( 1.94 g, 75%) as white needles: mp 
161.0°-162.0° C. (dee); IR (KBr)cm- 1 3440, 1105; 1H 
NMR (DMSOd6) 81.75 [d, !H, H(9), J = 13.7 Hz], 1.88 
(43) 
35 [d, !H, H(9), J = 13.6 Hz], 2.41 [br, s, 2H(l.5)]. 2.64 [d. 
2H, H(2,4)ax, J = 12.21 Hz], 3. 19 [d, 2H. H(2.4)eq, 
J = 12.10 Hz], 3.42 [m, 2H, H(6,8)ax], 3.61 [d. 2H. 
H(6,8)eq, J = 11.83 Hz], 4.32 [d, 2H. H(!0-NCH2), 
J =5.75 Hz]; 13C NMR (DMSO-d6) ppm 22.0 [C(2A-)], 
EXAMPLE V 
7-(3,4-Dimethoxy )phenethyl-3-selena-7-azabicy-
clo[3.3. l]nonan-9-one (44) 
40 25.2 [C(l,5)], 28.5 [C(9)], 56.6 (C(6,8)]. 60.5 [C(!0N-
CH2)], 128.9, 129.3, 129.8, 130.0 ]A· ]: 15N NMR 
(DMSO-d6) ppm 51.56 [N(7)]; 77Se N\. ~ (DMSO-d6) 
ppm 96.61 [Se(3)]. Analysis calculated for 
A solution was made of 3,4-dimethoxyphenethyla-
mine (2.23 g, 12.3 mmol) and glacial acetic acid (1.0 g, 45 
16.6 mmol) in methanol (60 mL). Paraformaldehyde 
(3.0 g, JOO mmol) was added and the resulting mixture 
was heated to boiling. 4-Selenanone (2.00 g, 12.3 mmol) 
was added and boiling was continued for 4 hours. The 
resulting brown solution was evaporated (aspirator) to a 50 
brown oil. This oil was added to water(! 50 mL) and the 
mixture which formed was extracted with ether ( 4 X 50 
mL). The combined extracts were washed with water 
(30 mL) and dried (K2CO3). Evaporation (aspirator) 
gave a dark brown oil which was digested in boiling 55 
Skelly B (3 X JOO mL). After decantation from a small 
amount of residual oil, evaporation of the supernatant 
gave 1.4 g of 7-(3,4-dimethoxy)phenethyl-3-selena-7-
azabicyclo[3.3. l]nonan-9-one as a pale yellow viscous 
oil (31%): IR (neat) cm-1 1730 (C==O);IH NMR 60 
(DCCI}) 82.60-2.80 [m, SH, H(2,4,l,5,10-ArCH2)], 
3.00-3.20 [m, 6H, H(6,8,I l-NCH2)], 3.80 (s, 3H, OCH3], 
3.84 [s, 3H, OCH3], 7.70-7.90 (m, 3H, ArH]; 13C NMR 
(DCCI}) ppm 25.4 [C(2,4)], 33.2 [C(!O-ArCH2)], 46.2 
(C(J,5)], 55.7 [both OCH3], 58.6 [C(l l-NCH2)], 59.1 65 
[C(6.8)], 111.3, 112.0, 120.5, 132.8 [C(l')], 141.2, 148.7, 
213.8 [C(9)]; 15N NMR (DCCl3) ppm 35.16 (N(7)]; 77Se 
NMR (DCCl3) ppm 77.00 [Se(3)]. Without further puri-
C14H20CINO4Se: C, 44.14; H, 5.30; N, 3.68: Cl. 9.32: 
Se. 20.75. Found: C, 44.45: H, 5.38: N, 3.61; Cl. 9.52; Se, 
20.67. 
(45) 
EXAMPLE VII 
7-(2-Thiophene)methyl-3-selena-7-azabicyclo(3.3. l]no-
nane Hydroperchlorate (46) 
7-(2-Thiophene)methyl-3-selena-7-azabicyclo(3.3. l-
]nonane Hydroperchlorate (1.0 g, 3.33 mmol) and anhy-
drous hydrazine (95%, 2.0 g, 5.94 mmol) were dissolved 
in triethylene glycol (40 mL) in a 60 mL, jacketed flask 
which was equipped for distillation. Potassium hydrox-
ide (85%, 3.0 g, 45.5 mmol) was added and the resulting 
mixture was heated with stirring to 140°-145° C. by 
boiling xylene in the jacket of the reaction vessel. Heat-
ing was continued for 4 hours after "-·hich time ihe 
reaction mixture \\·as cooled to room ,ccmperature and 
5,043,445 
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was poured into cool water (150 mL). The resulting 
suspension was extracted with ether (5 X 40 mL) and the 
combined extracts were dried (K2CO3). After filtration 
of the desiccant, 60% HClO4 (1.0 g, 6.0 mmol) was 
added dropwise, very slowly, causing an orange solid to 5 
form. The ether was decanted and the solid was recrys-
tallized twice (isopropyl alcohol, decolorizing carbon) 
to give 0.88 g of 7-(2-Thiophene)methyl-3-selena-7-
azabicyclo[3.3.l]nonane hydroperchlorate as white nee-
dles (68%): mp 141.0'-141.5" C.: IR (KBr) cm- 1 3450, 10 
1150; 1H NMR (DMSO-d6) ol.74 [d, lH, H(9), 1 = 13.6 
Hz], 1.86 [d, lH, H(9), 1 = 13.6 Hz], 2.43 [br s, 2H, 
H(l,5)], 2.64 [d, 2H, H(2,4)ax, 1=12.0 Hz], 3.19 [d, 2H, 
H(2,4),q, 1 = 11.3 Hz], 3.35 [m, 2H, H(6,8)ax], 3.62 [d, 
2H, H(6,8),q, 1 = 12.7 Hz], 4.53 [d, 12H, H(lO-NC!:!2), 15 
1=5.3 Hz], 7.16 [dd, lH, H(3'), 1=5.1 Hz, 3.7 Hz], 7.36 
728-7.50 [m, 5H, Ar-HJ, 8.89 [br s, IH, H(7)]; 13C NMR 
(DMSO-d6) ppm 21.9 [t, C(2,4)], 25.3 [d, C(l,5)], 28.5 [t, 
C(9) or C(l l-ArCH2)], 29.9 [t, C(l l-ArCH2) or C(9)], 
56.7 [y, C(6,8)], 58.8 [t, C(l0-NCH2)], 126.8 [d, C(4')], 
128.5 [d, C(2',6',3',5')], 136.2 [s, C(I ')]; 15N NMR 
(DMSO-d6) ppm 48.25 [N(7)]; 77Se NMR (DMSO-d6) 
ppm 88.42 [Se(3)]. Analysis calculated for 
C15H22CINO4Se: C, 45.64; H, 5.62; N, 3.55; Se, 20.00. 
Found C, 45. 77; H, 5.80; N, 3.48; Se, 19.85. 
Se 
H. CI04-
I -
N\ 
\_Ph 
(47) 
EXAMPLE IX 
7-p-Methoxyphenethyl-3-selena-7-azabicyclo[3.3. l ]no-
nane Hydroperchlorate (48) 
[d, lH, H(2'), 1 =3.3 Hz], 7.75 [d, lH, H(4'), 1 =5.1 Hz], 
9.24 [br s, lH, H(7)]; 13C NMR (DMSO-d6) ppm 21.9 [t, 
C(2,4)], 25.3 [d, C(l,5)], 28.6 [t, C(9)], 60.5 ]t, C(l0-
NCH2)], 56.2 (t, C(6,8)], 127.2 (d, C(4')], 129.3 [d, C(2')], 20 
130.5 [s, C(I')], 131.8 [d, C(3')]; 15N NMR (DMSO-d6) 
ppm 58.54 [N(7)]; 77Se NMR (DMSO-d6) ppm 89.41 
[Se(3)]. Analysis calculated for C12H1sCINO4Se: C, 
37.27; H, 4.69; N, 3.62; Se, 20.42. Found: C, 37.30; H, 
4.76; N, 3.60; Se, 20.10. 
Se 
H CI04-
I -
(46) 
A jacketed flask equipped for simple distillation was 
charged with a suspension of 7-p-methoxyphenethyl-3-
selena-7-azabicyclo[3.3. I ]nonan-9-one (0.65 g. I. 92 
25 mmol), hydrazine (95%, 1.00 g, 29.7 mmol), and potas-
sium hydroxide (85%, 3.0 g, 45.5 mmol) in triethylene 
glycol (25 mL). Under a rapid stream of nitrogen, the 
suspension was heated to 140° -145' C. by boiling xylene 
'b 30 in the jacket of the flask. Stirring was continued at this temperature for 3 hours during which time a small amount of water and excess hydrazine distilled from the reaction mixture. After cooling to room temperature, 
the resulting solution was diluted with water (100 mL) 
EXAMPLE VIII 
7-Phenethyl-3-selena-7-azabicyclo[3.3. !]nonane 
Hydroperchlorate ( 4 7) 
35 and was extracted with ether (5 X 40 mL). The com-· 
bined ether extracts were dried (K2CO3) overnight and 
60% perchloric acid (0.5 g, 3.0 mmol) was added very 
slowly. This precipitated an orange solid. The ether was 
decanted and the solid was recrystallized (absolute etha-
A jacketed flask was charged. with a mixture of 7- 40 
phenethyl-3-selena-7-azabicyclo[3.3. l]nonan-9-one (1.3 
g, 4.2 mmol) N2H4 (95%, 2.0 g; 59 mmol), and KOH 
(85%, 6.0 g, 91 mmol) in triethylene glycol (40 mL). 
The flask was equipped for simple distillation under a 
rapid stream of nitrogen. The reaction mixture .was 45 
heated to 140'-145' C. by boiling xylene contained in 
the jacket. Heating was continued under a nitrogen 
stream for 5 hours. During this time, a small amount of 
water and hydrazine distilled out. The resulting clear, 
light brown solution was cooled in a water bath to room 50 
temperature and was then poured into ice-water (200 
mL). The white suspension which formed was ex-
tracted with ether (5 X 40 mL). The combined ether 
extracts were washed with brine (30 mL) and dried 
(K2CO3) overnight. After filtering out the desiccant, 55 
this ether solution was cooled to 0' -5' C. in an ice bath 
and 60% HCIO4 (1.0 g, 6.0 mmol) was added dropwise, 
very slowly. After stirring overnight, the resulting 
orange precipitate was filtered and recrystallized (meth-
anol, decolorizing carbon) to give 0.67 g (40%) of 7- 60 
Phenethyl-3-selena-7-azabicyclo[3.3. l]nonane hy-
dr9perchlorate as white plates: mp 249' -250' C. (dee): 
IR (KBr) cm- 1 3400, 1140; 1H NMR (DMSO-d6) ol.73 
[br d, !H, H(9), 1 = 14.0 Hz], 1.89 [br, d, lH, H(9), 
1=13.8 Hz], 2.41 [br s, 2H, H(l,5)], 2.64 [d, 2H, 65 
H(2,4)ax, 1 = 12.1 Hz], 3.07 [t, 2H, H(l l-ArCH2), 1 = 7.9 
Hz], 3.20 [d, 2H, H(2,4)eq, 1 = 12.2 Hz], 3.33 [m, 4H, 
H(lO-NC!:!2), (6,8)ax], 3.86 [d, 2H, H(6,8)eq, 1 = 12.3 Hz], 
nol) with the aid of decolorizing carbon to give 0.58 g 
(71 % ) of7-p-methoxyphenethyl-3-selena-7-azabicy-
clo[3.3. l]nonane hydroperchlorate as white needles: mp 
208.5'-209.0' C.; IR (KBr) cm-I 3425, 1085; 1H NMR 
(DMSO-d6) ol.73 [br d, lH, H(9), 1= 14.0 Hz], 1.90 [br, 
d, lH, H(9), 1 = 14 Hz], 2.42 [br s, 2H, H(l.5)], 2.65 [d, 
2H, H(2,4)ax, 1 = 12 Hz], 3.02 [t, 2H, H(l l-ArCH2)], 
1 = 7 Hz], 3.22 [d, 2H, H(2,4), 1 :"' 14 Hz], 3.30 [m;°2H, 
H(l0-NCH2)], 3.36 [d, 2H, H(6.8)ax, 1 = 12 Hz], 3.76 [s, 
3H, OCH3], 3.86 [d, 2H, H(6,8)eq, 1 = 12 Hz], 6.97 [ct, 
2H, H(3',5'), 1=9 Hz], 7.32 [d, 2H, H(2',6'), 1=9 Hz], 
8.92 [br s, lH, H(7)]; 13C NMR (DMSO-d6) ppm 21.9 [t, 
C(2,4)], 25.3 [d, C(l,5)], 28.5 [t, C(9) or C(l l)], 28.9 [t, 
C(l l-ArCH2) or C(9)], 55.0 [q, OCH3], 56.7 [t, C(6,8)], 
58.9 [t, C(I0-NCH2)], 114.0 [d, C(3',5')], 127.7 [s, C(l')], 
129.6 [d, C(2',6')], 158.1 [s, C(4')], 15N NMR (DMSO-
d6) ppm 48.10 [N(7)]; 77Se NMR (DMSO-d6) ppm 88.64 
[Se(3)]. Analysis calculated for C16H24CINO5Se: C, 
45.24; H, 5.69; N, 3.30; Se, 18.59. Found: C. 45.42; H, 
5.80; N, 3.30; Se, 18.46. 
148) 
5,043,445 
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EXAMPLE X 
7-(3,4-Dimethoxy )phenethy-3-selena-7-azabicy-
clo[3.3.1 ]nonane Hydroperchlorate ( 49) 
A jacketed flask which was equipped for distillation, 5 
was charged with solution of 7-(3,4-dimethoxy)-
phenethyl-3-selena-7-azabicyclo[3.3. l)nonan-9-one 
(I. 10 g, 3.00 mmol), anhydrous hydrazine (95%, 200 g, 
5.94 mmol), and potassium hydroxide (85%, 3.0 g, 45.5 
mmol) in triethylene glycol (40 mL). This solution was 10 
heated to 140°-145° C. by boiling xylene in the jacket of 
the reaction flask. Heating was continued for 4 hours 
during which time a small amount of water and excess 
hydrazine distilled. The reaction mixture, which had 
turned brown, was cooled and poured into cool water 15 
(150 mL). The resulting suspension was extracted with 
ether (4X50 mL). The combined extracts were washed 
with water (40 mL) and dried (K2CO3). Perchloric acid 
(60%, 1.0 g, 6.0 mmol) was added to the ether solution 
dropwise, very slowly. This precipitated a white solid 20 
which rapidly turned orange. The ether was decanted 
and the solid was recrystallized twice from absolute 
ethanol (decolorizing carbon) to give 0.92 g (68%) of 
7-(3,4-dimethoxy )phenethy-3-selena-7-azabicyclo[3.3. l-
Jnonane hydroperchlorate as a white crystalline solid: 25 
mp 162°-163° C.; IR (KBr) cm-I 3450, 1090; IH NMR 
(DMSO-d6) ol.74 [d, IH, H(9), J=13 Hz], 1.92 [d, IH, 
H(9), J = 13 Hz], 2.42 [br, s, 2H, H(l,5), 2.65 (d, 2H, 
H(2,4)ax, J= 12 Hz], 3.02 [t, 2H, H(l l-ArCH2)], 3.22 [d, 
2H, H(2,4)eq, J = 12 Hz], 3.36 [n, 4H, H(I0-:-NC!:!2) and 3o 
H(6,8)ax], 3.76 [s, 3H, OCH3), 3.80 [x, 3H, OCH3), 3.87 
[d, 2H, H(6,8)eq, J = 12 Hz], 6.88-7.02 [m, 3H, ArH], 
8.88 [br s, IH, H(7)); 13C NMR (DMSO-d5) ppm 22.0 
[C(2,4)), 25.3 [C(l,5)], 28.5 [C(l l) or C(9)], 29.4 [C(9) or 
C(l l) ArCH2)], 55.4 [OCH3)), 56.7 [C(6,8)], 58.9 [C(I0)- 35 
NCH2)], 112.0, 112.3, 120.6, 128.3 [C(l'), 147.7 [C(3') or 
C(4')], 148.8 [C(3') or C(4')), 15N NMR (DMSO-d6) 
ppm 48.03 [N(7)); 77Se NMR (DMSO-d6) ppm 88.35 
Se(3)). Analysis calculated for C11H26ClNO6Se: C, 
44.90; H, 5.76; N, 3.08. Found: C, 44.86; H, 5.86; N, 3.04. 4o 
(49) 
2H, H(6,8)eq), 4.35 [d, 2H, H( I 0-NC!:!2)], 740-7.70 [m, 
5H, ArH], 9.20 [br s, IH, H(7)]; 13C NMR (DMSO°d6) 
ppm 21.1 [C(2,4)], 34.7 [C(l,5)], 54.9 [C(6,8)], 60.l 
[C(IO)-NCH2)], 92.5 [C(9)), 129.2, 129.7, 130.0, 130.5 
[Are]; 15N NMR (DMSO-d6) ppm 51.88 (N(7)]: 77Se 
NMR (DMSO-d6) ppm 62.39 [Se(3)]. Analysis calcu-
lated for C14H20NCISeO6: N, 3.39; Se, 19.13. Found: N, 
3.20; Se, 19.51. 
Se (50) f-'- Cl04-
N 
HO \_Ph 
OH 
EXAMPLE XII 
6, 8-Diphenyl-3-selena-7-azabicyclo[3.3. l )nonan-9-one 
(51) 
A jacketed flask was charged \vith a solution of dry 
ammonium acetate (2.31 g, 30,0 mmol) in absolute etha-
nol (30 mL) which was warmed to 65' C. by boiling 
methanol in the jacket. A solution of 4-selenanone (2.45 
g, 15.0 mmol) and benzaldehyde (3.18 g, 30.0 mmol) in 
absolute ethanol (15 mL) was added in one portion. The 
resulting solution was stirred under nitrogen at 65' C. 
for 45 minutes. After cooling the reaction mixture to 
about 30'-40° C., ether (15 mL) was added and stirring 
\vas continued for 10 minutes. Cooling (5' C.) overnighi 
resulted in the formation of a yellow solid which was 
filtered and recrystallized (ethanol) to give 0.89 g ( l 7o/c) 
of 6,8-diphenyl-3-selena-7-azabicyclo[3.3. l)nonan-9-one 
as white needles: mp 207.0° -208.5' C. (dee): IR (KBr) 
cm- 1 3320 (N-H), 1730 (C==O); 1N NMR (DCCl3) 
o 1. 77 [br s, IH, H(7)), 2.84 [br d, 4H, H(2,4), J = 8 Hz], 
3.59 [m, 2H, H(l,5)], 5.04 [m, 2H. H(6,8)], 7.20-7.50 [m, 
10 H,ArH]; 13C NMR (DCCl3) ppm 92.2 [C(2,4J]. 54.0 
[C(l.5)], 64.2 [C(6,8)], 144.4 [C(l'), 127.0 [C(3',5') or 
C(2',6')], 127.9 [C(4')], 128.7 [C(2',6') or C(3',5')] 207.2 
[C(9)]; 15N NMR (DCCl3) ppm 63.28 [N(7)): 77Se NMR 
(DCCl3) ppm 25.38 [Se(3)]. Analysis calculated for 
45 C19H19NOSe: C. 64.04; H, 5.38; N, 3.93; Se, 22. I 7. Found: C, 63.86; H, 5.45; N, 3.81; Se. 21.90. 
EXAMPLE XI 
7-Benzyl-3-selena-7-azabicyclo[3. 3.1 )nonan-9, 9-diol 
Hydroperchlorate (50) 
7-Benzyl-3-selena-7-azabicyclo[3.3. l]nonan-9-one 
50 
55 
(0.65 g, 2.2 mmol) was dissolved in dry benzene (250 
mL). Perchloric acid (60%, 1.0 g, 6.0 mmol) was added 
dropwise very slowly with cooling and swirling. This 60 
precipitated an orange solid which adhered to the side 
of the flask. The benzene was decanted and the solid 
was recrystallized (95% ethanol) to give 7-benzyl-3-
selena-7-azabicyclo[3.3. l]nonan-9,9-diol hydroperchlo-
rate (0.62 g, 68.3%) as white needles: mp 214.0'-216.0° 65 
C. (dee); IR (KBr) cm- 1 3430, 1080; 1H NMR (DMSO-
d6) 82.43 [br s, 2H, H(2.4)ax), 2.72 [br d, 2H, H(2,4)eq], 
3.22-3.50 [m, 6H, H(6,8)ax, H(l,5), O!:!), 350-3.64 [m, 
Ph 
HN :::::7 );;,, 
0 
(51) 
EXAMPLE XIII 
6,8-Di(2-thiophene)-3-selena-7-azabicyclo[3.3. I )nonan-
9-one (52) 
A solution of 2-thiophenecarboxaldehyde ( 1.38 g, 
12.3 mmol) and dry ammonium acetate (0.94 g, 12.3 
mmol) in absolute ethanol (20 mL) was heated to boil-
ing on a hot plate. To this was added a hot solution of 
freshly sublimed 4-selenanone 10 ( 1.00 g. 6. 13 mmol) in 
absolute ethanol (15 mL). Boiling \Vas continued for 10 
minutes with ethanol being added to keep the volume 
constant. During this time the colorless ~olution turned 
yellow. The flask was removed from the hot plate. was 
5,043,445 
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stoppered, and was allowed to stand at room tempera-
ture for 3 days. The resulting dark red solution was 
decanted from the yellow solid which had formed dur-
ing this time. The solid was taken up in benzene ( 100 
mL) and was treated with decolorized carbon. Filtra- 5 
tion followed by evaporation (aspirator) gave a light 
brown solid which was recrystallized (methanol) to 
give 0.40 g, (18%) of 6,8-Di(2-thiophene)-3-selena-7-
azabicyclo[3.3. l]nonan-9-one as a light yellow solid: mp 
155°-161° C. (dee); IR (KBr) cm- 13260 (N-H), 1723 10 
(C=O); 1H NMR (DCCl3) 62.16 [br s, IH, H(7)], 2.80 
[m, 4H, H(l,5) and H(2,4)ax], 3.57 [d, 2H, H(2,4)eq, 
J = 10.03 Hz], 5.32 [d, 2H, H(6,8), J = 3.96 Hz], 6.90-7.40 
[m, 6H, Ar-HJ; 13C NMR (DCCb) ppm 29.3 [C(2,4)], 
54.6 [C(l,5)], 59. I [C(6,8)], 123. 7, 124.8, 126.3 15 
[C(2',3',4')], 147.0 [C(l')], 213.3 [C(9)]; 15N NMR 
(DCCb) ppm 67.09 [N(7)]; 77Se NMR (DCC13) ppm 
30.60 [Se(3)]. 
[C(2',6') or C(3',5')], 128.8 [C(3',5') or C(2',6')], 133.7 
[C(4')], 142.5 [C(I')], 213.4 (9)); 15N NMR (DCCJ 3) ppm 
62.84 [N(7)]; 77Se NMR (DCCl3) ppm 26.67 [Se(3)]. 
6,8-Di( 4-chlorophenyl)-3-selena-7-azabicyclo[3.3. l-
]nonan-9-one (the endo,exo isomer) proved very diffi-
cult to purify for elementary analysis. It was converted 
to amine 6,8-di( 4-chlorophenyl)-3-selena-7-azabicy-
clo[3.3. l]nonane. 
Addition of water (lOmL) to the original mother 
liquor caused the precipitation of a dense brown solid. 
After allowing this mixture to stand at room tempera-
ture overnight, the solid was filtered and recrystallized 
(ethanol, decolorizing carbon) to give 0.2 g (7%) of 
6,8-di(4-chlorophenyl)-3-selena-7-azabicyclo[3.3. l]no-
nan-9,-one (the endo, endo isomer) as a light tan solid: 
mp 168°-171° C. (dee); IR (KBr) cm-1 3315 (N-H), 
1710 (C=O); 1H NMR (CDCl3) 62.68-2.90 [m, 2H, 
H(2,4)ax], 2.83 [br s, 2H, Hl,5)], 3.06-3.18 [m, 2H, 
H(2.4)eq], 4.48 [br s, 2H, H(6,8)], 7.30-7.60 [m, 8H, 
ArH]; 13C NMR (CDCl3) ppm 20.9 [t, C(2.4)], 51.5 [d. 
C(l,5)], 63.8 [d, C(6,8)], 127.7 [d, C(2') or C(3')]. 128.8 
[d, C(3') or C(2')], 133.4 [s, C(4')]. 137.6 [s. C(l')], 212.9 
[s, C(9)]; 15N NMR (CDCl3) ppm 44.24 [::s.;(7)]; 77Se 
6,8-Di(2-thiophene )-3-selena-7-azabicyclo[3.3. I ]no-
nan-9-one proved difficult to purify in order to obtain a 20 
satisfactory elemental analysis. Thus it was used di-
rectly in the conversion to the amine 6,8-di(2-thio-
phene)-3-selena-7-azabicyclo[3.3. l]nonane of Example 
XVI which did lend itself to purification and was ana-
lyzed. 25 NMR (CDCl3) ppm 122.66 [Se(3)]. 
(52) 
30 
35 
EXAMPLE XIV 
40 6,8-Di(4-chlorophenyl)-3-selena-7-azabicyclo[3.3. l]no-
nan-9-one (the endo,exo isomer) (53),(54) 
g-CIC6H4 
HN ::::7 
~~CIC6H4 
~Se 
0 
A solution of dry ammonium acetate (0.94 g, 12.3 EXAMPLE XV 
(5.1) 
()•) • 
mmol) and p-chlorobenzaldehyde (1. 73 g, 12.3 mmol) in 6,8-Diphenyl-3-selena-7-azabicyclo[3.3. l]nonane (55) 
absolute ethanol (20 mL) was heated to boiling in a 45 
50-mL, Erlenmeyer flask on a hot plate. To this solution 6,8-Diphenyl-3-selena-7-azabicyclo[3.3. l]nonan-
was added a boiling solution of freshly sublimed 4- 9-one (0.89 g, 2.5 mmol) and hydrazine (95%, 3.0 g, 89 
selenanone (1.00 g, 6.13 mmol) in absolute ethanol (15 mmol) were dissolved in triethylene glycol (40 mL). 
mL). The combined solutions were boiled for 10 min This solution was placed in a jacketed flask equipped 
with ethanol being added to keep the volume constant. 50 for simple distillation under a ·rapid stream of nitrogen. 
During this time the colorless solution became light Water was boiled in the jacket which heated the reac-
yellow. The flask was then removed from the hot plate tion mixture to about 100° C. The solution was stirred at 
and stoppered. The reaction mixture was allowed to this temperature for 2 hours. Potassium hydroxide 
stand at room temperature for 3 days, during which (85%, 1.0 g, 15 mmol) was added and the temperature 
time the solution turned dark reddish-brown and a ye!- 55 was increased to about 208° C. by boiling tetralin in the 
low solid formed. The liquid was decanted and the solid jacket. As the temperature increased a gas evolved, 
was dissolved in benzene (100 mL). This solution was presumably nitrogen. After stirring at this temperature 
treated with decolorizing carbon and was filtered. for 4 h, 3 mL of water and exce5s hydrazine had dis-
Evaporation (aspirator) of the benzene gave a light tilled out. The reaction mixture was cooled to 60° - 70° 
brown solid which was recrystallized (absolute ethanol) 60 C. and was then poured into ice-water (200 mL). The 
giving 0.33 g (13%) of 6,8-di(4-chlorophenyl)-3-selena- filtered solid was recrystallized (ether, decolorized car-
7-azabicyclo[3.3. l]nonan-9-one (the endo,exo isomer) as bon) to give 0.63 g (74%) of amine 6.8-diphenyl-3-
a light tan solid: mp 219° -220° C. (dee); IR (KBr) cm- I selena-7-azabicyclo[3.3. l]nonane as white needles: mp 
3280 (N-H), 1722 (C=O); 1H NMR (DCCJ3) 61.70 [br 193.5°-195.0° C. (dee); IR (KBr) cm-1 3250 (N-H): IH 
s, lH, H(7)], 2.69 [m, 4H, H(l,5) and H(2,4)ax], 3.56 [d, 65 NMR (C6D6) 60.83 [dt, lH, H(9), J = 12.0, 1.5 Hz], 1.34 
2H, H(2,4)eq, J = 10.20 Hz], 4.99 [d, 2H, H(6,8), J =4.07 [m, lH, H(7)], 1.78 [m, 2H, H(l,5)], 2.00 [dd, 2H, 
Hz], 7.30-7.40 [m, 8H, Ar-{-1]; 13C NMR·(DCCb) ppm H(2,4)ax, J = 12.0, 1.4 Hz], 2.33 [m, lH, H(9)], 2.84 [dd. 
29.0 [C(2,4)], 53.0 [C(l,50)], 63.4 [C(6,8)], 128.2, 2H, H(2,4)eq, J = 12.0, 2.0 Hz], 4.34 [d, 2H. H(6,8), 
5,043,445 
24 23 
J=2.0 Hz], 7.1-7.4 [m, lOH, ArH]; 13C NMR 
(D6D6@50° C.) ppm 25.1 [C(2,4)], 27.2 [C(9)), 34.5 
[C(l,5)), 62.0 [C(6,8)), 126.9 [C,(2') or C(3')], 127.2 
[C(4')), 128.7 [C(3') or C(2')], 151.9 [C(l')); 15N NMR 
(C6D6) ppm 55.68 [N(7)]; 77Se NMR (C6D6@50° C.) 5 
ppm 2.38 [Se(3)). Analysis calculated for C19H21NSe: 
C, 66.66; H, 6.18; N, 4.09; Se, 23.06. Found: C, 66.82; H, 
6.34; N, 3.97; Se, 22.82. 
EXAMPLE XVII 
6,8-Di( 4-chlorophenyl)-3-selena-7-azabicyclo[3.3. l ]no-
nane (57) 
Endo, exo 6,8-di(4-chlorophenyl)-3-selena-7-azabicy-
c!o[3.3. l]nonan-9-one (the endo, exo isomer) (2.00 g, 
4.71 mmol), anhydrous hydrazine (95%, 2.0 g, 60 
mmol), and triethylene glycol (35 mL) were placed in a 
Ph 10 
jacketed, round-bottomed flask along with a magnetic 
(55) stirring bar. The contents of the flask were heated to 
100° C. under a stream of nitrogen by boiling water in 
the jacket of the reaction flask. Stirring at this tempera-
ture was continued for 3 hours after which time potas-
HN ' 
'k;s, 
EXAMPLE XVI 
15 sium hydroxide (85%, 5.0 g, 76 mmol) was added in one 
portion. The reaction mixture was then heated to 
140°-145° C. by boiling xylene in the jacket. After 4 
hours at this temperature, the resulting solution was 
cooled (60°-70° C.) and was poured into water (100 
6,8-Di(2-thiophene)-3-selena-7-azabicyclo[3.3. l]nonane mL) which precipitated a cream-colored solid. This 
(56) 20 
solid was filtered and washed with water. Recrystalliza-
tion (twice, absolute ethanol, decolorizing carbon) gave 
6,8-di(4-chlorophenyl)-3-selena, 7-azabicyclo[3.3. l ]no-
nane as a light tan solid (0.91 g, 47%): mp 179°-180° C. 
25 (dee); IR (KBr) cm- 1 3260 (N-H); 1H NMR (DCCl3) 
o 1.30 [d, lH, H(7), J = 12 Hz], 1.74 [br s, lH, H(7)], 2.04 
]br s, 2H, H(l,5)], 2.28 [br d, 2H, H(2,4)ax, J = 12 Hz], 
2.48 [m, lH, H(9)], 3.17 [dd. 2H, H(2,4)eq, J = 12 Hz, 4 
6,8-Di(2-thiophene)-3-selena-7-azabicyclo[3.3. l]no-
nan-9-one (1.00 g, 2.71 mmol) and anhydrous hydrazine 
(95%, 1.0 g, 30 mmol) were dissolved in triethylene 
glycol (40 mL) which was contained in a jacketed flask 
equipped for distillation. By boiling water in the jacket, 
the reaction mixture was heated to 100° C. and stirred at 
this temperature for 2 hours. Potassium hydroxide 
(85%, 2.0 g, 30 mmol) was added in one portion and the 
water in the jacket then replaced by xylene which, 30 
when boiled, brought the temperature of the reaction 
mixture to 140°-145° C. Stirring was continued at this 
temperature for 5 hours. After cooling to room temper-
ature, the reaction mixture was poured into ice-cold 
water (200 mL) after which a precipitate immediately 35 
formed. This mixture was set aside at room temperature 
overnight and was then filtered. The filtrate was taken 
up in boiling benzene and treated with decoloring car-
bon. The benzene was evaporated (aspirator) and the 
residue was recrystallized in 95% ethanol to give 0.64 g 40 
(67%) of 6,8-di(2-thiophene)-3-selena-7-azabicy-
clo[3.3. l)nonane as a light tan solid: mp 183° -185° C. 
(dee); IR (KBr) cm- 1 3270 (N-H); 1H NMR (DCCl3) 
81.28 [d, lH, H(9), J = 13 Hz, 2 Hz], 1.78 [br s, lH, 
H(7)], 2. 18 [br s, 2H, H(l,5)], 2.32 [d, 2H, H(2,4)ax, 45 
J = 12 Hz], 2.50 [m, lH, H(9)], 3.20 [dd, 2H, H(2,4)eq, 
J = 13 Hz], 4.79 [d, 2H, H(6,8), J =4 Hz], 6.96 [dd, 2H, 
ArH]; 7.01 [2H, d, ArH], 7.21 [d, 2H, ArH]; 13C NMR 
(DCCl3) ppm 25.0 [C(2,4)], 25.8 [C(9)], 34.6 [C(l,5)], 
57.1 [C(6,8)], 122.2 [C,(4'), 122.6 [C(2')], 126.1 [C(3')]; 50 
150.7 [C(l')]; 15N NMR (DCCb) ppm 60.10 [N(7)]; 77Se 
NMR (DCCl3) ppm 4.05 [Se(3)]. 6,8-Di(2-thiophene)-3-
selena-7-azabicyclo[3.3. l]nonane proved difficult to 
purify for satisfactory analysis and was converted to 
6,8-Diphenyl-3-selena-7-azabicyclo[3.3.1]-nonane Hy- 55 
droperchlorate of Example XIX. 
(56) 
Hz], 4.43 [d, 2H, H(6.8), J = 5 Hz], 7.26-7.50 [m, 8H. · 
Ar HJ; 13C NMR (DCCl3) ppm 25.1 [C(2.4)], 26.9 [C(9)]. 
33.8 [C(l,5)], 60.9 [C(6,8)], 127.9, 128.6. 132.6 [C(4')] .. 
145.7 [C(l')], 15N :t-,;MR (DCCl3) ppm 55.37 [N(7)]; 77 Se 
NMR (DCCl3) ppm -0.79 [Se(3)]. 
6,8-Di( 4-chlorophenyl)-3-selena-7-azabicyclo[3.3. l-
]nonane proved exceedingly difficult to obtain in pure 
form and give a satisfactory analysis. Thus, it was con-
verted to the hydroperchlorate salt 6,8-di(4-chloro-
phenyl)-3-selena-7-azabicyclo[3.3. l]nonane hydroper-
chlorate of Example XXI which analyzed well. 
(57) 
EXAMPLE XVIII 
6,8-Di(4-chlorophenyl)-3-selena-7-azabicyclo[3.3. l]no-
nane (58) 
Endo, endo 6,8-di( 4-chlorophenyl)-3-selena-7-
azabicyclo[3.3. l ]nonan-9-one (the endo, exo isomer) 
(2.00 g, 4.71 mmol), anhydrous hydrazine (95%, 2.0 g, 
60 mmol), a~d triethylene glycol (35 mL) were placed 
in a 60-mL, two-necked, jacketed, round-bottomed 
flask along with a magnetic stirring bar. This mixture 
was heated to 100° C. by boiling water in the jacket of 
60 the reaction flask. Stirring at this temperature under a 
stream of nitrogen was continued for 2 hours at which 
time potassium hydroxide (85%, 5.0 g, 76 mmol) was 
added. The temperature of the resulting mixture was 
increased to 140° -145° C. by boiling xylene in the jacket 
65 of the reaction flask. After stirring at this temperature 
for 3 h, the resulting solution was cooled ( 60° - 70° C. 
and was poured into water (100 mL). This precipitated 
a light yellow solid \Vhich was filtered and washed with 
5,043,445 
26 25 
droperchlorate as white needles: mp 285' C. (dee); 1H 
NMR (DMSO-d6) 61.78 [d, IH, H(9), J = 14 Hz], 2.36 
[d, 2H, H(2,4)ax, 1 = 14 Hz], 2.44 [m, IH, H(9)], 2.66 [br 
s, 2H, H(l,5)], 3.19 [dd, 2H, H(2,4)eq, 1 = 12 Hz, 3 Hz], 
water. This solid was recrystallized (absolute ethanol, 
decolorizing carbon) to give 6,8-di(4-chlorophenyl)-3-
selena-7-azabicyclo[3.3. l]nonane as a white powder 
(1.14 g, 59%): mp 163°-165° C. (dee); IR (KBr) cm-I 
3290 (N-H); lH NMR (CDCb) 62.04 [br s, 2H, 
H(l,5)], 2.18 [d, !H(9)]; 1 = 14 Hz], 2.25 [d, 2H, H(2.4)ax, 
1 = 12 Hz], 2.36 [d, IH, H(9), 1 = 13 Hz], 2.59 [br s, IH, 
H(7)], 3.04 [dd, 2H, H(2,4),q, 1 = 12 H, 4 Hz], 4.50 [d, 
2H, H(6,8), 1=3 Hz], 7.32-7.52 [m, 8H, ArH]; 13C 
NMR (CDCL3) pmm 17. 7 [C(2,4)], 30.4 [C(l,5)], 35.0 
[C(9)], 64.0 [C(6,8)], 127.9, 128.5, 132.6 [C(4')], 141.1 
[C(l')]; 15N NMR (CDCL3) ppm 50.52 [N(7)]; 77Se 
NMR (CDCl3) ppm 101.86 Se(3)]. 
5 5.07 [m, 2H, H(6,8), 7.16 [dd, 2H, H(3'), 1=4 Hz. J=6 
Hz], 7.43 [d, 2H, H(2'), 1 =4 Hz], 7.69 [dd, 2H, H(4'), 
1=3 Hz, 1=6 Hz], 9.36 [br s, IH, H(7)], 9.61 [br s, IH, 
H(7)]; 13C NMR (DMSO-d6) ppm 23.5 [C(2,4)], 26.2 
[C(9)], 32.5 [C(l,5))], 56.1 [C(6,8)], 127.3 [C(2') ofC(4')], 
10 127.6 [C(4') or C(2')], 129.2 [C(3')], 138.9 [C(l')]; 15N 
NMR (DMSO-d6) ppm 62.39 [N(7)]; 77Se NMR 
(DMSO-d6) ppm 5.11 [Se(3)]. Analysis calculated for 
C15H1sCINO4S2Se: C, 39.61; H, 3.99; N, 3.08; S, 14.10; 
(58) 15 
EXAMPLE XIX 
6,8-Diphenyl-3-selena-7-azabicyclo[3.3. l]nonane 
Hydroperchlorate (59) 
A solution was made of 6,8-diphenyl-3-selena-7-
azabicyclo[3.3. l]nonane (0.63 g, 1.8 mmol) in benzene 
20 
25 
Se, 17.36. Found: C, 39.81; H, 3.97; N, 3.10; S, 14.35; Se, 
17.18. 
(60) 
CI04-H2N~ 
~} 
EXAMPLE XXI (100 mL). Perchloric acid (60%, 1.0 g, 6.0 mmol) was 
added dropwise, very slowly with swirling. The result-
30 ing mixture was allowed to stand at room temperature 6,8-Di( 4-chlorophenyl)-3-selena-7-azabicyclo[3 .3.1 ]no-
with occasional swirling for 3 hours. The orange solid nane Hydroperchlorate (61) 
which formed was filtered and recrystallized (metha- 6,8-Di(4-chlorophenyl)-3-selena-7-azabicyclo[3.3.1-
nol) to give 0.62 g (78%) of 6,8-diphenyl-3-selena-7- ]nonane (1.00 g, 2.43 mmol) was dissolved in ether (200 
azabicyclo[3.3. l ]nonane hydroperchlorate as white nee- 35 mL). Perchloric acid ( 60% ), 1.0 g, 6.0 mmol) was added· dies: mp 288.0° -289.0' C. (dee, sealed tube); lH NMR 
slowly with vigorous swirling. The resulting mixture 
(DMSO-d6) 61.78 [br d, lH, H(9), 1 = 13.0 Hz], 2-36 [br was allowed to stand for 24 hours with occasional swirl-
d, 2H, H(2,4)ax, 1 = 13.0 Hz], 2.59 [m, 3H, H(l,5) and · Th II J"d h' h ~ d . fil d 
H(9)], 3. 16 [dd, 2H, H(2,4),q, 1 = 12_0, 2_0 Hz], 4_73 [br d, mg. eye o_w-oran~e so I w 1c 1orme \\as I t_ere 
2H, H(6,8), 1 = 3.0 Hz], 7. 19_ 7_ 70 [m, !OH, ArH], 8_72 and recrystalhze_d (twice, absolute ethanol, decolonzmg [m, IH, H(7)ax], 9.67 [m, IH, H(7)eq]; 13C NMR 40 carb~m) to give 6,8-d1(4-chlorophenyl)-3-selena: 7-
(DMSO-d6) ppm 23.5 [C(2,4)], 26.6 [C(9)], 31.2 [C(l,5)], azab1cyclo[3.3. l]nona~e hydr~perc~lorate a\ a ,\:·h1te 
61.5 [C(6,8)], 128.5, 128.7, 128.6, 137_0 [C(l')]; 15N powder (0.46 g, 37%). mp 272 -274 C. (dee), H N~R 
NMR (DMSO-d6) ppm 57.91 [N(7)]; 77Se NMR (DMSO-d6) 61.77 [d, IH, H(9), 1 = 12.0 Hz], 2.36 [d, _H, (DMSO-d6) ppm 1.16 [Se(3)]. Analysis calculated for H(2,4)ax, l = 10-8 Hz], 2.53 [m, 2H, H(l,5)], 3.,14 [d. 2H, 
C19H22CINO4Se: C, 51.54; H, 5.01; N, 3.16; Se, 17.83. 45 H(2,4),q, 1= 10.5 Hz, 3.38 Hz], [br s, lH, H(9 ), 4.76 [br 
Found: C, 51.52; H, 4.94; N, 3.34; Se, 17.65. s, 2H, H(6,8)], 7.50-7.75 [m, 8H, ArH], 8.77 [br s, IH, 
Ph (59) 
H(7)], 9.59 [br s, lH, H(7)]; 13C NMR (DMSO-d6) ppm 
23.5 [C(2,4)], 26.5 [C(9)], 31.1 [C(l,5))], 60.6 [C(6,8)], 
128.5, 130.9, 133.8 [C(4')], 136.1 [C(l'); 15N NMR 
50 (DMSO-d6) ppm 57.67 [N(7)]; 77Se NMR (DMSO-d6) 
ppm 2.25 [Se(3)]. Analysis calculated for 
C19H20Cl3NO4Se: C, 44.60; H, 3.94; N, 2.47. Found: C, 
44.53; H, 3.84; N, 2.74. 
55 
EXAMPLE XX 
6,8-Di(2-thiophenyl-3-selena-7-azabicyclo[3.3. l]nonane 
Hydroperchlorate (60) 
A solution was made of 6,8-di(2-thiophenyl-3-selena- 60 
7-azabicyclo[3.3.l]nonane (0.5 g, 1.4 mmol) in benzene 
(200 mL) and isopropyl alcohol (10 mL). To this solu-
tion was added 60% HCJO4 (0.5 g, 3.0 mmol) dropwise 
slowly causing a white precipitate to form. This precipi-
tate quickly became yellow. The solvent was decanted 65 
and the solid was recrystallized twice (isopropyl alco-
hol, decolorized carbon) to give 0.4 g (63%) of 6,8-di(2-
thiophenyl)-3-selena-7-azabicyclo[3.3. l]nonane hy-
(61) 
EXAMPLE XXII 
6,8-Di(2-chlorophenyl)-3-selena-7-azabicyclo[3.3. l ]no-
nane Hydroperchlorate (62) 
6,8-Di( 4-chlorophenyl)-3-selena-7-azabicyclo[3.'3.1-
]nonane (1.00 g, 2.43 mmol) was dissolved in ether (200 
5,043,445 
27 
mL) in a 500 mL, round-bottomed flask. Perchloric acid 
(60%, 1.0 g, 6.0 mmol) was added slowly with swirling. 
The resulting mixture was allowed to stand at room 
temperature for 24 hours with occasional swirling. The 
orange solid which formed was filtered and recrystal- 5 
lized (absolute ethanol, decolorizing carbon) to give 
6,8-di(2-chloropheny 1)-3-selena-7-azabicyclo[3. 3. I no-
nane hydroperchlorate (0.36 g, 29%) as white needles: 
mp 264°-265° C. (dee); 1H NMR (DMSO-d6) 82.16 [d, 
IH, H(9), J=l2.1 Hz], 2.29 [d, 2H, H(2,4)ax, 1=12.7 10 
Hz], 2.50 [m, 3H, H(l,5), H(9)], 3.13 [d, 2H, H(2,4)eq, 
J=12.3 Hz, 5.07 [d, 2H, H(6,8), 1=8.5 Hz], 7.58-7.90 
[m, 8H, ArH], 9.18 [br s, IH, H(7)], 10.46 [br s, IH, 
H(7)]; 13C NMR (DMSO-d6) ppm 17.7 [C(2,4)], 29.7 
[C(l.5)], 32.0 [C(9)], 63.7 [C(6,8)], 128.6, 128.9, 133.2 15 
[C(4')], 134.5 [C(l')]; 15N NMR DMSO-d6) ppm 49.57 
[N(7); 77Se NMR (DMSO-d6) ppm 74.96 [Se(3)]. Analy-
sis calculated for C19H20Cl3NO4Se.C2H5OH: C, 45.22; 
28 
NMR (DCCb) 82.52 [br s, 2H, H(l,5)], 2.77. 2.78 (two 
d, 1 = 10.7 Hz, 4H, H(2,4,6,8)ax], 3.00 [br d. 1 = 10.5 Hz, 
4H, H(2,4,6,8)eq], 3.53 [s, 4H, ArCH2], 7.23-7.30 [m, 
!OH, ArH]; 13C NMR (DCCl3) ppm 46.7 (d, C(l,5)], 
58.01 [t, C(2,4,6,8)], 61.1 [t. ArCH2], 126.90 [d, p-ArC], 
128.02 [d, o- or m-ArC], 128.53 [d, m- or o-ArC] 138.02 
[s, i-ArC], 214.0 [s, C(9)]; 15N NMR (DCCl3) ppm 39.25 
[N(3, 7)]. 
EXAMPLE XXIV 
N,N' -Dibenzyl-3, 7-diazabicyclo(3.3. l]nonan-9-one (63) 
In a minor modification of the previous procedure, a 
solution of 1-benzyl-4-piperidone (4.73 g, 25.0 mmol) 
and glacial acetic acid (1.50 g, 25.0 mmol) in methanol 
(25 mL) was added as before to a boiling mixture of 
paraformaldehyde (6.00 g, 200 mmol), glacial acetic 
acid (1.62 g, 27.0 mmol), benzylamine (2.68 g, 25.0 
mmol), and methanol (100 mL). The reaction time was H, 4.70; N, 2.51; Se, 14.16. Found: C, 44.93; H, 4.39; N, 
2.58; Se, 14.43. 
(62) 
20 24 hours and the aqueous workup \\las as described 
previously. Instead of the distillation described. the 
crude oil from the workup was then digested in Skelly 
B (300 mL) on a steam bath for 0.5 hours. The hot 
supernatant was decanted from the yellow residue and 
EXAMPLE XXIII 
25 evaporated (aspirator followed by vacuum pump. room 
temperature 0.02 mm Hg, 20 min). This afforded N,:\l'-
dibenzyl-3, 7-diazabicyclo(3.3. l]nonan-9-one (6.84 g, 
85.4%) as a white oil that did not solidify after 3 days at 
- 10' C. The 1 H and 13C NMR spectra of this oil were· 
N ,N' -Dibenzyl-3, 7-diazabicyclo[3. 3 .1 ]nonan-9-one ( 63) 
30 virtually identical to that described for the ketone pro-
duced in Example XXIII via method A and the material· 
proved to be satisfactory for use in the following Exam-
ples XXV and XXVI. 
Following a procedure similar to that disclosed in 
U.S. Pat. No. 3,962,449, a three-necked, 50-mL, round-
bottomed flask was fitted with a dropping funnel (60 
mL), a condenser with an N2 inlet, a heating mantle, and 35 
a magnetic stirrer. This flask was charged with a solu-
tion of benzylamine (2.68 g, 25.0 mmol) and glacial 
acetic acid (1.54 g, 25.8 mmol) in methanol (25 mL). To 
this solution was added paraformaldehyde (1.58 g, 52.5 
mmol); then the apparatus was flushed with N2 and the 40 
mixture was brought to reflux with stirring. After 15 
min, a solution of l-benzyl-4-piperidone (4.73 g, 25.0 
mmol) and glacial acetic acid (1.50 g, 25.0 mmol) in 
methanol (18 mL) was added over 0.5 hours. The result-
ing orange solution was then boiled at reflux for an 45 
additional 9.5 hours. The mixture was then cooled to 
room temperature and the solvent was evaporated (as-
pirator) to give an orange oil. Water (50 mL) and KOH 
pellets (85%, 3.30 g, 50.0 mmol) were added, and the 
resulting oily, orange suspension was extracted 50 
(CH2Cl2, 3 X 50 mL). The organic extracts were com-
bined and dried (MgSO4, overnight). Filtration of the 
mixture followed by evaporation (aspirator) afforded an 
orange oil which was vacuum distilled (8X 10-7 mm 
Hg, diffusion pump). At 106'-108° C .. there was col- 55 
lected a colorless oil (0.36 g), the 13C NMR of which 
was identical to 1-benzyl-4-piperdone. A second frac-
tion (bp 180' -205° C.) was collected as a yellow oil but 
with substantial decomposition of the residue. This 
second fraction was redistilled (180°-185° C., 1.0 60 
x IQ-6 mm Hg) to yield again a yellow oil. This oil was 
dissolved in hot Skelly B (80 mL) and, upon cooling to 
-10° C., pure N,N'-dibenzyl-3,7-diazabicyclo(3.3.l]no-
nan-9-one (2.53 g, 31.6%) was precipitated as a while 
solid: mp 61°-63° C. (literature 70'-71° C. The com- 65 
pound was used in the next step without further purifi-
cation. The spectroscopic data for this compound were: 
IR (KBr) cm- 1 2963, 2822, 1738, 1721, 748, 703 lH 
0 
Ph 
P'~, }>0 Ph 
EXAMPLE XXV 
N,N' -Dibenzyl-3, 7-diazabicyclo[3.3. I ]nonane 
Hydroperchlorate (64) 
(63) 
Following a procedure similar to that disclosed in 
U.S. Pat. No. 3,962,449, for the synthesis ofN,N'-diben-
zyl-3, 7-diazabicyclo(3.3. l]nonane, a jacketed two-
necked, 70-mL flask was fitted with a lower take-off 
condenser with an N2 inlet and a receiving flask, a ther-
mometer, a condenser on the jacket, a magnetic stirrer, 
and a heating mantle. This flask was charged with N,N'-
dibenzyl-3.7-diazabicyclo[3.3.l]nonan-9-one (2.00 g, 
6.24 mmol), hydrazine hydrate (85%, 1.10 g, 18.7 
mmol), KOH pellets (85%, 2.06 g, 31.2 mmol), and 
triethylene glycol (25 mL). The apparatus was flushed 
with N2, and the mixture heated at 120' C. for 0.5 hours 
using tetralin (bp 207' C.) in the jacket. The reaction 
mixture was then allowed to boil at reflux for 5 hours. 
The temperature slowly increased to 207' C. with re-
moval of the volatile distillates and with the evolution 
of N2. The reaction mixture was cooled to room tem-
perature and was poured, along with the distillate. into 
cool water (30 mL), which resulted in the formation of 
a white suspension. This was extracted (ether. 4'/30 
mL), and the combined extracts were washed ~ucces-
5,043,445 
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sively with NaOH solution (10%, 30 mL), H2O (30 dibenzyl-9,9-dimethoxy-3,7-diazabicyclo[3.3. l]nonane 
mL), and NaCl solution (saturated, 30 mL). After dry- hydroperchlorate (0.9103 g) as small white crystals, mp 
ing (Na2SO4, overnight), the solution was filtered and 223.6'-224.0' C. (dee). The mother liquor was concen-
evaporated (aspirator) to give the crude amine, N,N'- trated to approximately 10 mL. Upon cooling at -10' 
dibenzyl-3,7-diazabicyclo[3.3.l]nonane as a yellow oil 5 c. overnight, a second crop of N,N'-dibenzyl-9.9-dime-
(1.34 g, 70.1 %). This oil was dissolved in C6H6 (20 mL) thoxy-3, 7-diazabicyclo[3.3. l]nonane hydroperchlorate 
and treated dropwise over 15 min with a solution of was obtained (89.4 mg, total: 0.9997 g, 68.6% total), mp 
HCIO4 (60%, 2.20 g, 13.1 mmol) in 2-propanol (5 mL) 219'-220° C. (dee). The spectral data were as follows: 
to give a dark solution. This solution was stirred (mag- IR (KBr) cm-12800-2600 (N+-H), J JOO (Cl-O); IH 
netic) for 1 hour after which it was concentrated (5 10 NMR (DMSO-d6) 82.35 [br s, 2H, H(l,5)], 2.90 [d, 
mL). Addition of ether (20 mL) precipitated the salt as 6 ] 3 [ d k b l.d p·J · 11 . . 1 = 13 Hz, 4H, H(2,4, ,8)ax , .08 d, 1 = 13, 4H, a ar rown so 1 . 1 tratton and recrysta 1zat1on (aqueous ethanol, 20 mL, decolorizing carbon) afforded H(2,4•6•8)eq], 3· 14 [s, 6H, C!:!30), 3·88 [s, 4H, ArCH2], 
a first crop of N,N'-dibenzyl-3,7-diazabicyclo[3.3.l]no- 7·38- 7·54 [m, lOH, ArH), 9-84 [br s, lH, N+-H]; ITc-
nane hydroperchlorate (0.652 g) as the monoperchlo- 15 NMR (DMSO-d6) ppm 33 .o [d, C(l,5)], 46.96 [q, 
rate; mp 221° -222° C. Concentration of the mother CH30], 53·8 [t, C(2,4,6,8)], 59-56 [t, ArCH2], 95.36 [s, 
liquor to 7 mL gave a second crop (0.126 g, total: o. 778 C(9)), 128.22 [d, p-ArC], 128:4 [d, o_- ~r m:ArC], 129.62 
g, 43.7% total), mp 220•-222• C. The spectroscopic [d, m- or o-ArC], 133.45 [s, t-ArC),. n NMR DMSO-
data for this compound were: IR (KBr) cm- I 2960, d6) ppm 52.89 [N(3, 7)). Analysis calculated for 
2841 (C-H), 2800-2600 (N+-H), 1100, 1080 (Cl-O); 20 C23H31CIN2O6: C, 59. 16; H, 6.69; Cl, 7.59; N, 6.00. 
IH NMR (DMSO-d6) 81.72 [br s, 2H, H(9)), 2.14 [br s, Found: C, 58.98; H, 6.81; Cl, 7.86; N, 6.28. 
2H, H(l,5)], 2.77 [d, 1=13 Hz, 4H, H(2,4,6,8))ax], 3.13 
[d, J = 13 Hz, 4H, H(2,4,6,8)eq], 3.43 ]br s, lH, N-"--H], 
3.86 [s, 4H, ArCH2], 7.30-7.48 [m, lOH, ArH]; ITc 
NMR (DMSO-d6)ppm 27.4 [d, C(l,5)], 29.54 [t," C(9)], 25 
56.97 [t, C(2,4,6,8)], 60.4 [t, ArCH2], 128.2 [d, p-ArC], 
128.4 [d,o- or m-ArC), 129.6 [d, m- or o-ArC), 133.30 [s, 
i-ArC]; 15NMR (DMSO-d6) ppm 54.59 [N(3,7)]. Analy-
sis calculated for C21H21CIN2O4: C, 61.99; H, 6.69; Cl, 
8.71; N, 6.88. Found: C, 61.92; H, 6.84; Cl, 8.71, N, 6.82. 30 [Although the N,N' -dibenzyl-3, 7-diazabicyclo[3.3. l]no-
nane hydroperchlorate was supposedly synthesized (see 
Ruenitz, P. C. and Smissman, E. E. J. Heterocy. Chem. 
(Ph (b5) 
~ c10.-
"- -H 
:-,:\ 
H3CO Ph 
OCH3 
EXAMPLE XXVII 
1976, 13, 1111), the material was not a true pure com- 7-Benzyl-9,9-dimethoxy-3-thia-7-azabicyclo[3.3. l]no-
pound since it has a melting range of 210°-217° C. and 35 nane Hydroperchlorate (66) 
orange crystals were reported; therefore, the above data 
is for the true, pure compound)] 
Ph 
N; CI04-
I + 
N\ 
Ph 
(64) 
40 
A one-necked, 100 mL, round-bottomed flask was 
fitted with a Soxhlet containing 3A molecular sieve (30 
g), a condenser, an N2 inlet, a heating mantle, a mag-
netic stirrer, and a heating mantle. The effective cycling 
volume of the Soxhlet was approximately 15 mL. The 
flask was charged with a solution of N-benzyl-3-thia-7-
azabicyclo[3.3. l)nonan-9-one [1.00 g, 4.04 mmol) in 
methanol (20 mL) and benzene (20 mL). To this solu-
EXAMPLE XXVI 
N,N' -Dibenzyl-9,9-dimethoxy-3, 7-diazabicyclo[3.3.1-
]nonane Hydroperchlorate (65) 
45 tion was added HClO4 (60%, 2.03 g, 12.1 mmol) in one 
portion. The volume of the methanol used was such that 
the perchloric acid always remained in solution and did 
not become completely dry. The apparatus was flushed 
with N2 and the pale yellow solution was heated at 
A one-necked, 100-mL, round-bottomed flask was 50 
equipped with a Soxhlet containing 3A molecular sieve 
(30 g), a condenser with N2 inlet, a magnetic stirrer and 
a heating mantle. The effective cycling volume of the 
Soxhlet was approximately 20 mL. The flask was 
charged with a solution ofN,N'-dibenzyl-3,7-diazabicy- 55 
clo[3.3.l]nonan-9-one (1.00 g, 3.12 mmol) in CH3OH 
(25 mL) and C6H6 (25 mL) to which was added HCIO4 
(60%, 1.50 g, 8.96 mmol) in one portion. The volume of 
the methanol used was such that the perchloric acid 
always remained in solution and did not become com- 60 
pletely dry. The apparatus was flushed with N2 and the 
colorless solution was heated to reflux with cycling 
through the Soxhlet. After 24 h, the now pale yellow 
solution was .cooled to room temperature and concen-
trated to about 15 mL. Upon standing for a few minutes, 65 
a product precipitated as a white solid which was fil-
tered, washed with C6H6 (10 mL), and recrystallized 
(CH3OH, 80 mL) to afford the monoperchlorate N,N'-
reflux with stirring and cycling through the Soxhlet for 
24 hours. The solution was cooled.to room temperature 
and concentrated to about 5 mL. Ether (20 mL) was 
added, thus precipitating the salt as a powder. This was 
filtered, washed with ether (5 mL), and dissolved in hot 
methanol (20 mL, decolorizing carbon). Trituration 
with ether (25 mL), followed by standing for 24 h, 
afforded 7-benzyl-9,9-dimethoxy-3-thia-7-azabicy-
clo[3.3. l]nonane hydroperchlorate (0. 7345 g, 46.2%) as 
small white crystals: mp 193°-194° C. (dee); IR (KBr) 
cm- 1 2800-2600 (N+-H), 1090 (Cl-O); IH NMR 
(DMSO-d6) 82.58 [br s, 2H, H(l,5)], 2.75 [d, 1 = 14 Hz, 
2H, H(2,4)ax], 3.15-3.18 [m, 8H. H(2,4)eq,CH3O], 3.38 
[dd or br t, 1 = 12 Hz, 2H. H(6.8)ax], 3.60 [d.J = 12 Hz, 
H(6,8)eq], 4.33 [d, 1=5 Hz, 2H, ArCH2], 7.49-7.62 [m, 
SH, ArH], 9.28 [br s, lH, N.,.-H]; 13C NMR (DMSO-
d6) ppm 28.78 [t, C(2,4)], 32.20[d, C(l,5)], 46.60 [q, 
CH3O], 47.00 [q, CH3O], 54.42 [t, C/6.8)]. 60.24 ]t, 
ArCH2], 95. l [s, C(9)], 129.0 [d, o- or m-ArC]. 129.46 [s. 
5,043,445 
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(N-H), 1717 (C=O); 1H NMR (DCCl3) 82.54 [d, 
J = 12 Hz, 2H, H(6,8)ax], 2.76 [br s, 2H, H(l ,5)], 3.12 [d, 
J = 12 Hz, 2H, H(6,8)eq], 3.32 [s, 2H, ArCH2], 4.70 [br s, 
!H, N-H], 4.80 [br s, 2H, H(2,4)], 7.15-7.60 [m,ArH]; 
i-ArC], 130.1 [d, p-ArC), 130.2 [d, m- or o-ArC]; 15N 
NMR (DMSO-d6) ppm 53.49 [N(7)]. Analysis calcu-
lated for C26H24CJCO6: C, 48. 79; H, 6.14; Cl, 9.00; N, 
3.56; S, 8.14. Found: C, 48.73; H, 6.09; CI, 9.39; N, 3.54; 
S, 8.40. 
SH Cl04-
(66) 
I + 
N\ 
5 13C NMR (DCCl3) ppm 50.90 [d, C(l,5)], 55.S0(t, 
C(6,8)], 62.11 [d, C(2,4)], 62.54 [t, ArCH2], 126.62, 
127.44, 128.45, 128.57, 129.75, 129.81, 129.90, 132.32, 
136.66, 137.22 [ArC], 212.22 [s, C(9)); 15N NMR 
(DCCI}) ppm 46.90 [N(7)], 54.45 [N(3)]. Analysis calcu-
H3CO Ph 
OCH3 
10 lated for the endo, exo- isomer C26H24Cl2N2O: C, 69.18; 
H, 5.36; Cl, 15.71; N, 6.21. Found: C, 69.31, H, 5.20; Cl, 
15.83; N, 6.18. Analysis calculated for the endo, endo-7-
benzyl-2,4-bis(2-chlorophenyl)-3, 7-diazabicyclo(3.3. l-
]nonan-9-one of 17 Calcd. for C26H24Cl2N 20: C. 69 .18; 
EXAMPLE XXVIII 
endo, exo- and endo, 
15 H, 5.36; CI, 15.71; N, 6.21. Found: C, 69.33; H, 5.53; Cl, 
15.97; N, 6.09. 
endo-7-Benzyl-2,4-bis(2-chlorophenyl)-3, 7-diazabicy-
clo[3.3. l)nonan-9-ones (67),(68) 
A three-necked, 50 mL, round-bottomed flask was 20 
fitted with a condenser, an addition funnel, a thermome-
ter, magnetic stirrer, a heating mantle, and an N2 inlet. 
This flask was charged ammonium acetate (NH4OAc, 
2.31 g, 30.0 mmol) and ethanol (10 mL) and the flask 
flushed with N2. The slurry was warmed to 40' C. with 25 
stirring until all NH4OAc dissolved, then the solution 
was cooled to room temperature. A solution of 2-
chlorobenzaldehyde (5.67 g, 40.3 mmol), 1-benzyl-4-
piperidone (3. 78 g, 20.0 mmol), and deoxygenated etha-
nol (-15 mL) was added in one portion. The resulting 30 
solution was slowly warmed to 70' C. over· 30 minutes. 
Upon cooling to room temperature, a white precipitate 
(solid A) formed which was filtered and washed with 
dry ether (20 mL). These washings were combined with 
the original filtrate and this solution was cooled at -10' 35 
C. for I hour to give a second solid precipitate (solid B) 
which was also filtered and set aside. Evaporation of the 
filtrate afforded an oily orange solid which was dis-
solved in ether (10 mL). Upon standing for 1 hour at 
- 10' C., a third white solid (solid C) precipitated. This 40 
too was filtered and set aside. Upon standing for 24 h, a 
fourth white solid (solid D) was precipitated, which 
was also filtered and set aside. Upon standing for 22 
days at - 10' C., a small amount of a fifth solid (solid E) 
precipitated which was treated as before. 45 
Solid A was recrystallized (2-propanol/HCC13, 3: !, 
40 mL) to afford pure endo, exo-3-7-benzyl-2,4-bis(2-
chlorophenyl)-3, 7-diazabicyclo[3.3. l]nonan-9-one (1.06 
g) as long white needles: mp 184'-185' C. IR (KBr) 
cm-1 3340 (N-H), 1733 (C=O); lH NMR (DCCI)) d 50 
1.61 [s, !H, N-H], 2.54, 2.56 [overlapping d, J = 12 Hz, 
and br s, 4H, H(i,5) and H(6,8)ax], 3.49 (d, J = 12 Hz, 
2H, H(6.8)eq], 3.73 [s, 2H, ArCH2], 5.50 [br s, 2H, 
H(2,4)], 7.14-7.80 [m, 13H, ArH];l 3C NMR (DCCl3) 
ppm 55.15 [d, C(l,5)], 58.77 (t, C(6,8)], 59.02 [d, C(2,4)], 55 
60.99 [t, ArCH2], 127.35, 127.48, 128.38, 128.44, 128.59, 
129.16, 129.21, 132.15, 138.35, 142.63 [ArC], 211.95 [s, 
C(9)]; 15N NMR (DCCl3) ppm 38.31 [N(7)], 58.24 
[N(3)]. 
Solids B, C and E were combined and recrystallized 60 
(2-propanol/HCCI}, 3:1, 15 mL) to afford additional 
endo, exo-3-7-benzyl-2,4-bis(2-chlorophenyl)-3, 7-
diazabicyclo[3.3. l]nonan-9-one (0.50 g, total: 1.56 g, 
17.3%) mp 184'-185' C. Solid D was also recrystallized 
from the same solvent system (15 mL) to afford endo, 65 
endo-7-benzyl-2,4-bis(2-chlorophenyl)-3, 7-diazacy-
clo[3.3.1 ]nonan-9-one (0.36 g, 4.0%) as short white 
needles: mp 209.5' -210.0' C.; IR (KBr) cm-1 3270 
0 
. :-,;fcoH4 
'.\'\ 
Ph 
EXAMPLE XXIX 
endo,exo-7-Benzyl-2,4-bis(2-chlorophenyl)-3. 7-
diazabicyclo(3.3. l]nonan-9-one (67) 
(67) 
(68) 
A one-necked, 50mL, round-bottom flask was fitted 
with a condenser, a magnetic stirrer, and an N2 inlet at 
the top of the condenser. The flask \Vas charged with 
95% ethanol (50 mL) and the apparatus was flushed 
with N2. This solvent was heated at reflux for 0.5 hours. 
Upon cooling to room temperature, l-benzyl-4-piperi-
done (4.73 g, 25.0 mmol), 2-chlorobenzaldehyde (7.03 g. 
50.0 mmol), and ammonium acetate (5. 78 g, 75.0 mmol) 
were added to the flask. The apparatus was again 
flushed with N2 and the mixture was allowed to stir at 
room temperature. The NH4OAc slowly dissolved over 
I hour and the formation of a small amount of white 
precipitate was noted shortly thereafter. Continued 
stirring at room temperature for 5 days gave additional 
white precipitate while the supernatant slowly devel-
oped a bright red-orange color. The precipitate (solid 
A) was filtered and washed with ether (50 mL). The 
washings were combined with the original filtrate. This 
solution was cooled at - 10' C. for 2 days, thus precipi-
tating additional white solid (solid B) which was filtered 
and washed with ether. The filtrate was evaporated 
(aspirator) to give an orange gum. Ether (100 mL) was 
added and the mixture was heated on a steam bath until 
a third, almost white solid separated from the orange 
supernatant. This was filtered, \vashed with ether and 
recrystallized (2-propanol/HCCl3, 3: 1. 10 mL) to afford 
endo,endo-7-benzyl-2,4-bis(2-chloropheny 1)-3, 7-
diazabicyclo( 3 .3. l]nonane (0. I 983 g, 1.8%) as tiny nee-
dles, mp 207'-209' C. 
Solid A was recrystallized (2-propanol/HCC13, 3: I. 
110 mL) to afford (3.14 g) as long white needles, mp 
5,043,445 
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184.0° -184.5° C. Solid B was recrystallized in the same 
solvent system (15 mL) to give endo,exo-7-benzyl-2,4-
bis(2-chlorophenyl)-3, 7-diazabicyclo[3.3. l nonan-9-one 
(0.40 g, total: 3.54 g, 31.3%), mp 184°-185° C. The IR, 
1H and !3C NMR spectra for these products were iden- 5 
tical to those given previously. 
EXAMPLEXXX 
N2, and the mixture was heated to 110' C. with stirring 
to dissolve the ketone. Hydrazine hydrate (85%, 1.22 g, 
20.7 mmol) was added in one portion and the resulting 
solution was heated at 110°-120° C. for I hour. Potas-
sium hydroxide pellets (85%, 8.8 g) were then added 
and the resulting mixture was heated to 195' C. over 4 
endo,exo-7-Benzyl-2,4-bis(2-chlorophenyl)-3, 7-
diazabicyclo[3.3. l]nonane (69) 
A two-necked, jacketed flask with an N2 inlet was 
fitted with a thermometer, a lower take-off condenser, a 
magnetic stirrer, a heating mantle, and a condenser on 
the jacket. The flask was charged with endo,exo-7-ben-
hours with the distillation of volatiles and the evolution 
of N2. After cooling to room temperature, the solution 
was poured into H2O (50 mL) and the resulting suspen-
10 sion was extracted with ether (7 X 50 mL). The com-
bined ether extracts were washed with NaOH solution 
(10%, 100 mL) and dried (K2CO3, overnight). Filtra-
tion, followed by evaporation (aspirator), of the filtrate 
zyl-2,4-bis(2-chlorophenyl)-3, 7-diazabicyclo[3.3.1 ]no- 15 
nan-9-one (0.80 g, 1.8 mmol) and triethylene glycol (50 
mL), and the jacket charged with tetralin (bp 207'). The 
apparatus was flushed with N2 and warmed to 110' C. 
with stirring to dissolve the ketone. To this solution was 
added in one portion hydrazine hydrate (85%, 0.52 g, 20 
10.4 mmol), and the resulting solution was stirred at 110 
• C. for 1 hour. Potassium hydroxide pellets (85%, 5.00 
g) were then added. The mixture was heated to 195' C. 
over 4.5 hours until N2 evolution ceased, with the con-
tinuous distillation of volatiles. Upon cooling to room 25 
temperature, the tan solution was poured into H2O (50 
mL), and the resulting suspension was extracted with 
ethyl ether (5 X 30 mL). The combined ether extracts 
were washed with NaOH solution (10%, 50 mL) and 
dried (Na2SO4, overnight). Filtration followed by evap- 30 
oration (aspirator) of the filtrate afforded a yellow oil 
which was dissolved in hot ethanol (25 mL). Upon 
cooling, the product precipitated as white plates which 
were filtered and dried to afford exo,exo-7-benzyl-2,9-
bis(2-chlorophenyl)-3, 7-azabicyclo[.3-.3. l]nonane (0.54 35 
g, 69%): mp 136.4'-137.0° C.; IR (KBr) cm- 1 3300 
(N-H); IH NMR (DCCIJ) ol.07 [dt, 1= 12.3, 2.7 Hz, 
!H, H(9)endo], 1.18 [br s, IH, N-H], 1.83 [br s, 2H, 
H(l ,5)], 2.09 [d, 1 = 10 Hz, 2H, H(6,8)ax], 2.35 [d, 
J = 12.3 Hz, lH, H(9)exo], 3.08 [d, 1 = 10 Hz, 2H, 40 
H(6,8)ax], 3.50 [s, 2H, ArCH2], 4.77 [d, 1=2.5 Hz, 2H, 
H(2,4)], 7.09-7.92 [m, 13H;-ArH]; 13C NMR (DCC)J) 
ppm 24.55 [b, C(9)], 36.13 [d, C(l,5)], 56.08 [d, C(2,4)], 
58.76 [t, C(6,8)], 62.85 [t, ArCH2], 126.79, 126.97, 
127.52, 128.02, 128.08. 129. 14, 129.27, 132.38, 139.19, 45 
145.66 [ArC]; 15N NMR (DCCl3) ppm 38.15 [N(7)], 
50.48 [N(3). Analysis calculated for C26H26N2Cli; C, 
71.39; H, 6.00; N, 6.40; CL, 16.21. Found: C, 71.17; H, 
gave a yellow oil which was dissolved in warm ethanol 
(50 mL). Trituration with ether afforded, upon cooling, 
white cubic crystals which were filtered, washed with 
ether, and dried to give endo, endo-7-benzyl-2.4-bis(2-
chlorophenyl)-3,7-diazabicyclo[3.3. l]nonane (1.11 g, 
61%): mp 149°-151' C.; IR (KBr) cm-1 3250 (N-H); 
1H NMR (DCCl3) 02.04 [br s, 2H, H(l,5)], 2.06 [d. 
1 = 10 Hz, !H, H(9)], 2. 17 [d, 1 = 10 Hz, 2H, H(6,8)ax], 
2.29 [d, 1 = 10 Hz, !H, H(9)], 2.82 [d, 1 = 10 Hz. 2H, 
H(6,8)eq], 3.10 [s, 2H, ArCH2], 4.44 [br s. !H, N-H], 
4.68 [br s, 2H, H(2,4)], 7.0S:::.7.44 [m, 13H, ArH]; l3C 
NMR (DCCl3) ppm 31.50 [d, C(l,5)], 35.87 [t-:-C(9)], 
54.86 [t, C(6.8)], 61.63 [d, C(2,4)], 64.31 [t. ArCH2], 
126.46, 127.33, 127.54, 128.25, 129.34, 129.80, 132.34, 
138.04, 140.20 [ArC]; 15N NMR (DCCl3) ppm 47.43 
(N(7)], 53.80 [N(3)]. Analysis calculated for C26H26 
Cl2N2: C, 71.39: H, 6.00: Cl, 16.21; N, 6.40. Found: C, 
71.48; H, 6.04; Cl, 16.00; H, 6.65. 
N~6H4 
N\ 
Ph 
EXAMPLE XXXII 
endo,exo-7-Benzyl-2,4-bis(2-chlorophenyl)-3. 7-
diazabicyclo[3.3. l]nonane Hydroperchlorate (71) 
(701. 
In a one-necked, 100-mL. round-bottomed flask. a 
solution of endo,exo-7-benzyl-2,4-bis(2-chlorophenyl)-
3, 7-diazabicyclo[3.3. l]nonane (0.80 g, 1.83 mmol) in 
C6H6 (30 mL) was treated dropwise slowly with a solu-6.25; N, 6.32; Cl, 16.15. 
(69) 
50 tion of HCLO4 (60%, 1.50 g, ·8.96 mmol) in 2-propanol 
(5 mL) which resulted in the formation of a white pow-
dery precipitate. The flask was fitted with a condenser, 
and the mixture was heated on a steam bath for 15 min. 
After cooling to room temperature, the precipitate was 
55 filtered and recrystallized in a minimum amount of 70% 
acetone to afford the monohydroperchlorate endo,exo-
7-benzyl-2,4-bis(2-chlorophenyl)-3, 7-diazabicy-
clo[3.3. l ]nonane hydroperchlorate as fine white crys-
tals: mp 246° -247° C. (dee): IR (KBr) cm - 1 3330 endo,endo-7-Benzyl-2,4-bis(2-chlorophenyl)-3, 7-
diazabicyclo[3.3.1 ]nonane (70) 60 (N-H), 2900-2600 (N-'--H), 1110 (Cl-O); IH NMR 
(DMSO-d6) ol.70 [d, 1 = 14 Hz, lH, H(9)endo], 2.33 [d, 
J = 11 Hz, 2H, H(6,8)ax], 2.38 ]br s, 2H, H(l.5)], 2.51 
[overlapping d, 1 = 14 Hz, H(9)exo and br s. DYISO], 
A jacketed two-necked flask with an N2 inlet was 
fitted with a thermometer, a lower take-off condenser 
with receiving flask, a magnetic stirrer, a heating man-
tle, and a condenser on the jacket. This flask was 
charged with endo,endo-7-benzyl-2,4-bis(2-chloro- 65 
phenyl)-3,7-diazabicyclo[3.3.l]nonane (1.87 g, 4.15 
mmol) and triethylene gl)(col (75 mL) and the jacket 
charged with tetralin. The apparatus was flushed with 
2.85 [d, 1 = 11 Hz, 2H, H(6,8)eq], 3. 70 [s. 2H. ArCH2], 
5.00 [d, 1=8 Hz, H(2,4)], 7.32-7.94 [m, 13H, ArH], 8.10 
[br s, lH, N-H], 9.84 br s, IH, N-r-H]; 13CNMR 
(DMSO-d6) ppm 24.54 [t, C(9)], 33.70 [d:-c(l.5)], 55.94 
[t, C(6,8)], 56.85 [d, C(2,4)]. 60.93 [t. C(I0)]. 
5,043,445 
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127.55-130.88 [m, ArC], 132.63, 135.51, 137.09 [ArC]; 
15NMR (DMSO-d5) ppm 38.30 [N(7)], 54.60 [N(3)]. 
Analysis calculated for C26H21CIJN2: C, 58.06; H, 5.06; 
Cl, 19.78; N, 5.21. Found: C, 58.16; H, 5.20; Cl, 19.65; N, 
EXAMPLE XXXIV 
3,6-Dibenzylhexahydro-8a-methoxy-5!!-4a,8-(methano-
thiomethano )-2H-pyrido[3 ,4-e ]-1, 3-oxazine and 
5.16. 5 2,4, 10, 12-Tetrabenzyl-2,4, 10, 12-tetraaza- l 5-thia-dis-
piro(5.1.5.3]hexadecan-7-one (73 ),(74) 
(71) 
EXAMPLE XXXIII 
endo, 
IO 
A three-necked, 50-mL, round-bottomed flask was 
fitted with a condenser, an N2 inlet, a magnetic stirrer, 
and a heating mantle. This flask was charged with para-
formaldehyde (1.20 g, 40.0 mmol), benzylamine (1.07 g, 
10.0 mmol), glacial acetic acid (0.66 g, I 1.0 mmol), and 
methanol (20 mL). The apparatus was flushed with N2 
and the mixture boiled at reflux with stirring for 15 
15 minutes. To the mixture was added in one portion a 
solution of 4-thianone (0.58 g, 5.0 mmol) in methanol 
(10 mL) and the resulting mixture was heated at reflux 
for 9 hours during which the paraformaldehyde slowly 
dissolved and the solution turned yellow. The solution 
endo-7-Benzyl-2,4-bis(2-chlorophenyl)-3, 7-diazabicy-
clo(3.3.1. ]nonane Hydroperchlorate (72) 20 
was then cooled to room temperature and allowed to 
stir an additional 10 hours. Evaporation afforded a yel-
In a one-necked, 100-mL, round-bottomed flask, a low oil which was partitioned between ethyl ether (50 
solution of endo, endo-7-benzyl-2,4-bis(2-chloro- mL) and water 50 mL). The layers were separated and 
phenyl)-3,7-diazabicyclo[3.3. l]nonane (0.4957 g, 1.14 the pale yellow ether layer was allowed to stand for 24 
mmol) in c6H6 (20 mL) was treated dropwise over 15 25 hours at -10° C. A white crystalline solid precipitated from this ethereal solution. This was filtered and set 
minutes with HClO4 (60%, 0.5 mL) with vigorous stir-
aside. The filtrate was concentrated (aspirator) to half 
ring. This resulted in the precipitation of a white solid. of the previous volume and allowed 10 stand for 3 
The flask was fitted with a condenser and heated on a hours. A second crop of the white solid was precipi--
steam bath for an additional 5 minutes, followed by lated which was filtered, combined \Vith the first crop. 
cooling to room temperature. The solution was filtered 30 and recrystallized (95% ethanol, 30 mL) to afford 3,6~ 
and the cloudy filtrate set aside. Recrystallization of this dibenzylhexahydro-8a-methoxy-5H-4a,8-(methanothi-
solid (CH3OH, 30 mL) afforded the monoperchlorate omethano)-2H-pyrido[3,4-e]-1,3-oxazine (0.93 g, 45%) 
endo, endo-7-benzyl-2,4-bis(2-chlorophenyl)-3,7- as white needles: mp 147.2'-148.8° C.; IR (KBr) cm-I 
diazabicyclo[3.3. l]nonane hydroperchlorate (0.1050 g) 35 3030, 2940, 2830, 1365, 1358, I 104, 1067. 740. 704; IH. 
as white crystals, mp 264.0° -264.5° C. (dee.) The cloudy NMR (DCCl3) 82.08 [d, J = 12 Hz, lH, H(5)ax], 2.13 [br 
benzene filtrate was evaporated to about 2 mL, and the s, IH, H(8)], 2.37 [d, J = 12 Hz, lH, H(5)eq], 2.54 [dd, 
resulting oil was dissolved in hot CH3OH (30 mL). J = 12, 2 Hz, lH, H(9)ax], 2.62 [d, J = 11 Hz, lH, 
Upon cooling to RT, additional salt precipitated as a ArCH2], 2.74 [d, J = IO Hz, IH, H(4)ax], 2.95 [d, J = IO 
white powder which was filtered and recrystallized 40 Hz, IH, H(4)eq], 3.22 [s, 3H, CH3O], 3.25 [d, J = 1 H, 
(CH3OH, 65 mL) to afford additional endo, endo-7-ben- H(l l)eq], 3.31 [d, J = I~ Hz, IH, H(7)ax], 3.39 [dd, 
zyl-2,4-bis(2-chlorophenyl)-3, 7-diazabicyclo[3.3. !]no- J = 12, 2 Hz, lH, H(9)eq], 3.49 [d, J = 11 Hz, lH, 
nane hydroperchlorate (0.3575 g, 74% total) as white ArCH2], 3.50 [d, J = 13 Hz, lH, H(7)eq], 3.55 [d, J = 13 
crystals, mp 260° -262° C. (dee). The spectroscopic data Hz, IB, ArC!!2], 4.02 ]d, J = 8 Hz, IH, H(2)ax], 4.18 [d, 
were as follows: IR (KBr) cm - I 3300 (N-H), 45 J = 8 Hz lH, H(2)eq], 7.22-7.38 [m, 8H, Ar!!], 7.58 [d, 
2850-2700(N+-H) 1090(CI-O)· IHNMR(DMSO- 1=8 Hz, 2H, Ar!!]; 13C NMR (DCCI}) ppm 30.09 [t, 
d ) 82 19 [d J -12 H lH H(9)] 2 35 [d _ 12 H 1H C(9)], 33.42 [d, C(8)], 34.56 [t, C(l 1)], 37.40 [s, C(4a)], 
H
6( )] . 8 '[b- 2Hz,H(l,5)] 3 0' 2 .[b ' 4-H H(z6' 8) ' 46.27 [q, CH3O], 55.38 [t, C(4)], 55.79 [t, C(5)], 57.32 [t, 9 , 2.3 rs, ' ' ' · rs, ' ' ax C(7)], 59.94 [t, ArCH2], 62.59 [t, ArCH2], 78.72 [t, C(2)], 
and eq], 4.08 [br s, 2H, ArC!:!2], 4-88 [br s, 2H, H(2,4), 50 96.9'3 [s, C(8a)], 126.48 [d, p-ArC], 127.10 [d, p-ArC], 
5.63 [br s, lH, N-H], 7.36-7. 72 [m, 13, Ar!!], 10.14 [br 128.15, 128.30, 128.33, 128.53, [o- and m-ArC], 137.49 [s, 
s, lH, N+-!!]; 13C NMR (DMSO-d6) ppm 29.77 [d, i-ArC], 139.66 [s, i-ArC]; 15N NMR (DCCJ3) ppm 46.42 
C(l,5)], 31.39 (t, C(9)], 52.97 (t, C(6,8], 60.30 [t, ArCH2], [N(3)], 35.92 [N(3)]. 
60.84 [d, C(2,4)], 127.33, 127.40, 128.92, 129.26, 129.89, In a separate experiment under slightly different con-
130.83, 131.18, 131.33, 136.33, 142.05, [ArC]; 15N NMR 55 ditions a second product was also isolated. A three 
(DMSO-d6) ppm 50.05 (N(7)], 52.56 [N(3)]. Analysis necked, 50 mL, round-bottomed flask was fitted with a 
calculated for C26H21CIJN2O4: C, 58.05; H, 5.07; Cl, dropping addition funnel, a condenser with an N 2 inlet, 
19.73; N, 5.21. Found: C, 58.07; H, 5.08; Cl, 19.66; N, a heating mantle, a magnetic stirrer, and a stopper on 
5.27. the third neck. The flask was charged with a slurry of 
(72) 
60 paraformaldehyde (1.20 g, 40.0 mmol) in methanol (20 
mL) and was heated at reflux under N2 with stirring 
(magnetic) for 15 minutes. To this boiling mixture was 
added dropwise over 3.5 hours a solution of 4-thianone 
(0.58 g, 5.0 mmol), benzylamine (1.07 g, 10.0 mmol), 
65 glacial acetic acid (0.66 g, 11.0 mmol) in methanol (10 
mL). During the addition the paraformaldehyde slO\vly 
dissolved and the solution turned to an orange-red 
color. The solution was heated at reflux for an addi-
5,043,445 
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EXAMPLE XXXV 
37 
tional 3.5 hours, and then allowed to stir at room tem-
perature for 48 hours. A white solid precipitated from 
the now pink solution. This solid was filtered, washed 
with methanol (5 mL) and recrystallized (2-propanol, 
30 mL) to afford 2,4, IO, 12-tetrabenzyl-2,4, IO, 12-tet- 5 
raaza-15-thia-dispiro[ 5 .1.5 .3 ]hexadecan-7-one (0.261 g, 
8.5% relative to the amount of benzylamine used) as 
white needles: mp 172.5'-173.5° C.; IR (KBr) cm- 1 
3065, 3030, 2950, 2920, 2895, 2830, 2800, 1680 (C=O), 
1500, 1457, 1097, 748, 736, 703; 1H NMR (DCCl3) 62.17 10 
[d, 1=10.8 Hz, 4H, H(l,5,9,13)ax], 2.50 [d, 1=8.8 Hz, 
2H, H(3,l l)ax], 2.77 [d, 1 = 10.8 Hz, 4H H(l,5,9,13)eq], 
3.15 [s, 4H, H(l4,16)], 3.33 [d, 1 = 13.0 Hz, 4H, ArC!!2], 
3.49 [d, 1 = 13.0 Hz, 4H, ArCH], 3.62 [d, 1 = 8.8 Hz, 2H, 
H(3,l 1)], 7.20-7.30 [m, 20H, Ar!!]; !3C NMR (DCCl3) 15 
ppm 36.43 [t, C(l4,16)], 51.26 [s, C(6,8)], 57.63 [t, 
C(l,5,9,13)), 59.57 [t, ArCH2], 76.58 [t, C(3, 11)), 127.06 
[d, p-ArC], 128.19 [d, o- or m-ArC], 128.55 [d, m- or 
o-ArC]. 137.77 [s, i-ArC], 211.73 [s, C(7)]; 15N NMR 
20 (DCCl3) ppm 43.06 [N(2,4,10,12)]. 
The reaction mixture filtrate was evaporated (aspira-
tor) to an orange-red oil which was partitioned between 
ether (50 mL) and water (50 mL). The ether layer was 
treated as before to afford after recrystallization ( etha-
nol, 25 mL) 3,6-Dibenzylhexahydro-8a-methoxy-5H- 25 
4a,8-(methanothiomethano )-2H-pyrido-[3,4-e )-1,3-oxa-
zine (0.212 g, 11%), mp 146.5'-148.0' C.; the 13C NMR 
spectrum of which was identical to that given pre_vi-
ously. The pink aqueous suspension was made alkaline 
by the addition of NaOH pellets (0.50 g, 12.5 mmol) to 30 
give a yellow suspension. This suspension was extracted 
with ether ( 4 X 50 mL) and the combined ether extracts 
were dried (Na2SO4, overnight). The dry ethereal solu-
tion was filtered and evaporated (aspirator) and the 
resulting yellow oil was digested in boiling Skelly B 35 
(200 mL) for 30 minutes. The hot supernatant was _de-
canted from the brown residue and evaporated (aspira-
tor) followed by vaccuum pump) to leave a pale yellow 
oil. The !3C NMR (DCCI3) of this oil indicated that is 40 was mostly N-benzyl-3-thia-7-azabicyclo[3.3. I]nonan-
9-one (0.59 g, approximately with a small amount of 
3,6-Dibenzylhexahydro-8a-methoxy-5!!-4a,8-(methano-
thiomethano )-2H-pyrido-[3,4-e]-1,3-oxazine present as 
an impurity. Analysis calculated for 3,6-dibenzylhex- 45 
ahydro-8a-methox y-5!!-4a, 8-( methanothiomethano )-
2H-pyrido-[3,4-e ]-1,3-oxazine C24H30N 2O2S: C, 70.21; 
H-;7.37; N, 6.82; S, 7.81. Found: C, 69.99; H, 7.51; N, 
6.64; S, 7.97. Analysis calculated for 2,4, 10, 12-tetraben-
zyl-2,4, IO, 12-tetraaza-l 5-thiadispiro[5. I .5.3]hexadecan-
50 7-one C39H44N4SO: C, 75.94; H, 7.19; N, 9.08; S, 5.20. 
Found: C, 75.73; H, 7.33; N, 9.10; S, 5.20. 
(73) 
3,6-Dibenzylhexahydro-8a-methoxy-5!!-4a,8-(me-
thanoselenomethano)-2H-pyrido[3,4-e]-l,3-oxazine and 
2,4, I 0, J 2-tetrabenzyl-2,4, I 0, 12-tetraaza- l 5-selenadis-
piro[5. l .5.3]hexadecan-7-one (75),(76) 
A three-necked, 50-mL, round-bottomed flask was 
equipped with a condenser, an N2 inlet, a heating man-
tle, and a magnetic stirrer. The flask was charged with 
benzylamine (0.67 g, 6.2 mmol), glacial acetic acid (0.38 
g, 6.3 mmol), paraformaldehyde (1.50 g, 50.0 mmol), 
and methanol (30 mL). The apparatus was flushed with 
N, and the mixture was heated to reflux with stirring. 
After 0.5 hours, the mixture was cooled to room tem-
perature and 4-selenanone [0.75 g, 4.6 mmol] was added 
in one portion. The mixture was again heated at reflux 
for 5 hours during which all solids dissolved and the 
resulting solution turned yellow. The solution was then 
cooled to room temperature and allowed to stir over-
night. The solvent was evaporated (aspirator) to leave a 
yellow oil which was partitioned between water (50 
mL) and ether (50mL). The layers were separated and 
the ether layer was allowed to stand for two days at 
room temperature during which a white solid precipi-
tate formed in this solution. This was filtered and re-
crystallized (95% ethanol, 25 mL) to afford 3,6-diben-
zylhexahydro-8a-methoxy-5!!-4a,8-(methanoselenome-
thano)-2H-pyrido[3,4-e]-1,3-oxazine (0.250 g) as wh1te 
needles: mp 160.0'-160.5' C. 
The aqueous layer was .cooled (ice bath) and was 
made alkaline by the addition of KOH pellets (85%, 
1.20 g, 21.4 mmol). The resulting suspension was ex-
tracted (ether, 5 X 40 mL) and the combined extracts_ 
were dried (K2CO3, overnight). Filtration, followed by 
evaporation (aspirator), afforded a yellow oil which 
was digested in hexanes (50 mL) for 0.5 hours on a 
steam bath. The hot supernatant was decanted and 
evaporated to give another yellow oil. This was dis-
solved in hot 96% ethanol (10 mL) which, upon cool-
ing, precipitated additional 3,6-dibenzylhexahydro-8a-
methox y-5 H-4a, 8-( methanoselenomethano )-2!!-
pyrido[ 3 ,4-e ]- I, 3-oxazine (67.0 mg, total: 0.317 g, 22%) 
mp 159'-160' C. 
The spectroscopic data for 3,6-dibenzylhexahydro-
8a-methoxy-5 H-4a, 8-( methanose lenomethano )-2!!-
pyrido[ 3, 4-e ]-f.' 3-oxazine· were: IR (KBr) cm- 1 2840, 
1370, 1362, 1108, 1062, 1055, 762, 706; 1H NMR 
(DCCI)) 62.09 [br s, IH, H(8)], 2. 11 [d, 1 = 11 Hz, IH, 
H(5)ax], 2. 13 [d, 1 = 12 Hz, IH, H(l l)ax], 2.37 [d, 1 = 11 
Hz, IH, H(5)eq], 2.53 [d, 1 = 11 Hz; IH, H(9)ax], 2.58 [d, 
1 = l I Hz, IH, ArC!!2], 2.72 [d, 1 = l I Hz, IH, H(4)ax], 
2.93 [d, 1 = 11 Hz, IH, H(4)eq), 3.25 [s, 3H, C!!3O], 3.29 
[d, 1 = 12 Hz, IH, H(I l)eq], 3.29 [d, J = 14 Hz, IH, 
55 H(7)ax], 3.44 [d, J = 11 Hz, IH, ArC!!2], 3.47 [d, J = 11 
Hz, IH, H(9)eq], 3.51 [d, J = 14 Hz, IH, H(7)eq], 3.53 [d, 
J =4 Hz, 2H, ArCH2], 3.97 [d, J =8 Hz, IH, H(2)ax], 
4.21 [d, J =8 Hz, lH, H(2)ax], 7.26-7.64 [m, !OH, Ar!!]; 
!3C NMR (DCCl3) ppm 20. I 1 [t, C(9)], 25.13 [t, C(l !)], 
(74) 
60 33.22 [d, C(8)], 36.84 [s, C(4a)], 46.51 [q, CH3O], 56.13 
[t, C(4)], 56.67 [t, C(5)], 57.26 [t, C(7)], 60.55 [t, ArCH2], 
62.63 [t, ArCH2], 78.76 [t, C(2)], 97.68 [s, C(8a)], 126.47 
(d), 127.09 (d), 128.11 (d), 128.27 (d), 128.47 (d), 128.52 
(d), 137.43 (s), 139.57 (s), [Are]; I 5N ::--.MR (DCCl3) 
65 ppm 36.20 [N(I2)], 47.00 [N(3)]; 77Se ~'.\IR ppm 126.55 
[Se(8)]. 
In a separate experiment two other products were 
also isolated. A three-necked, 50 mL, round-bottomed 
5,043,445 
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flask was fitted with a condenser, an N2 inlet, a heating 
mantle, a magnetic stirrer, and two stoppers. The flask 
was charged with a solution of benzylamine (1.07 g, 
10.0 mmol), glacial acetic acid (0.62 g, 10.3 mmol), 
paraformaldehyde (1.20 g, 40.0 mmol), and methanol 5 
(25 mL). The apparatus was flushed with Nz and the 
mixture heated at reflux with stirring for 15 min. 4-
Selenanone (0.83 g, 5.0 mmol) was then added in one 
position and the mixture heated at reflux for 5 hours. 
The supernatant turned yellow upon addition of 4- 10 
selenanone. With continued heating, the paraformalde-
hyde slowly dissolved and the solution turned to a pink 
color. After about 3 hours, the formation of a white 
precipitate was noted. The reaction mixture was cooled 
to room temperature and stirred an additional 13 hours. 15 
The white solid was filtered from the reaction mixture, 
washed with methanol (5 mL) and recrystallized (95% 
2-propanol, 20 mL) to give 2,4, 10, 12-tetrabenzyl-
2,4, 10, 12-tetraaza-15-selenadispiro[5. l.5.3]hexadecan-
7-one (57.6 mg. 1.9%) as white crystals: mp 165°-166° 20 
C.; IR (KBr) cm- 1 3062, 3032, 2910, 2820, 2792, 1675, 
1494, 1453, 1086, 1068, 741,729,697; IH NMR (DCCIJ) 
62.28 [d, 1 = 11.2 Hz, 4H, H(l,5,9, 13)ax], 2.55 [d, 1 = 8.1 
Hz, 2H, H(3, 11 )ax], 2. 77 [ d, 1 = 11.2 Hz, 4H, 
H(l,5,9,13)eq], 3.17 [s, 4H, H(14,16)], 3.34 [d, 1=13.5 25 
Hz, 4H, ArC!!2], 3.50 [d, 1 = 13.5 [Hz, 4H, ArCH2], 3.54 
[d, 1 =8.1 Hz, 2H, H(3,1 l)eq], 7.20-7.30 [m, 20H, ArH]; 
13C NMR (DCCl3) ppm 26.67 [t, C(l4,15)), 51.12ls, 
C(6,8)], 58.35 [t, C(l ,5,9, 13)], 59.58 [T, ArCH2], 126.93 
[d, p-ArC], 128.05 [d, o- or m-ArC], 128.46 [d, m- or 30 
o-ArC], 137.67 [s, i-ArC], 211.80 [s, C(7)]; 15N NMR 
(DCCl3) ppm 43.57. 
The reaction mixture filtrate was evaporated (aspira-
tor) to leave a pink oil which was partitioned between 
ether (50 mL) and water (50 mL). The colorless ether 35 
layer was separated and treated as before to afford after 
recrystallization 3,6-dibenzylhexahydro-8a-methoxy-
5!!-4_a, 8-(methanoselenomethano )-2!!-pyrido[3,4-e ]-1, 3-
oxazme (0.2030 g, 8.8%), mp 159°-160° C., the IR and 
13C NMR spectra of which were identical to that given 40 
pre~iously. The pink aqueous suspension from the parti-
t1onmg was made alkaline by the addition of KOH pel-
lets (85%, 200 g, 30.3 mmol) to give an oily yellow 
suspension. This suspension was extracted with ether 
(5 X 40 mL) and the con:ibined extracts dried (K2CO3, 45 
overnight). The ethereal extracts were then filtered and 
evaporated to leave an orange oil which was digested in 
boiling hexanes (50 mL) for 30 min. The hot supernatant 
was decanted and evaporated to give a yellow oil. This 
was dissolved in hot 9'5% ethanol (30 mL), decolorized 50 
with carbon, and evaporated to 10 mL. Upon standing 
at -10° C. for 1 day, white needles precipitated. These 
were filtered and air dried to afford 7-benzyl-3-selena-7-
azabicyclo[3.3. l]nonan-9-one (0.38 g, 25.8%), mp 
91°-92° C. Analysis calculated for 3,6-dibenzylhexahy- 55 
dro-8a-methoxy-5 !!-4a, 8-(methanoselenomethano )-2H-
pyrido[3 ,4-e ]-1, 3-oxazine C24H30N2O2Se: C, 63.01; H, 
6.61; N, 6.12; Se, 17.26. Found: C, 62.88; H, 6.83; N, 
6.02; Se, 16.91. 
60 
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EXAMPLE XXXVI 
3,6-Dibenzylhexahydro-8a-methoxy-5H-4a,8-(methano-
thiomethano )-2H-pyrido[3,4-e ]-T."3-oxazine 
dihydroperchlorate (77) 
A 125-mL, Erlenmeyer flask was charged with a 
solution of ketal 3,6-dibenzylhexahydro-8a-methoxy-
5!!-4a,8-(methanothiomethano )-2H-pyrido[3,4-e ]-1,3-
oxazine (1.00 g, 2.44 mmol) in benzene (20 mL). To this 
solution was added dropwise over 15 min a solution of 
HCIO4 (60%, 1.00 g, 5.97 mmol) in 2-propanol (5 mL) · 
with vigorous stirring (magnetic). This precipitated the 
salt as a white powdery solid. To prevent caking of the 
precipitate it was found necessary to add additional 
2-propanol (IQ mL). The mixture was stirred an addi-
tional 1 hour at room temperature. The salt was filtered 
recrystallized (ethanol, 25 mL), and dried (Abderhal'. 
den, P2O5, 77° C., vacuum pump, 12 hours) to afford 
3,6-dibenzylhexahydro-8a-methoxy-5H-4a.8-(methano- . 
thiomethano )-2!!-pyrido[3,4-e]-1,3-oxazine dihydroper-
chlorate (0.60 g, 40%) as white crystals: mp 160° -162' 
C. (dee); IR (KBr) cm- 1 2760-2845 (N--H), 1080 
(CL-O); 1H NMR (DMSO-d6) 82.17 [d. 1 = l 1.7 Hz, 
IH, H(4)az], 2.35 [d, 1 = 11.7 Hz, IH, H(4)eq], 2.43 [d, 
1 = 13.0 Hz, IH, H(l l)ax], 2.64 [br s. IH, H(8)], 2.76 [d, 
1 = l 3.6 Hz, IH, H(9)ax], 3.00 [d, 1 = l 3.0 Hz, H(l 1 )eq], 
3.18 [s, 3H, C!!3O], 3.22 [m, 2H, H(9)eq and ArCH2], 
3.32 [d, 1=13.6 Hz, IH, H(5)ax], 3.46 [d, 1=12.0Hz, 
H(7)ax], 3.57 [d, 1 = 13.6 Hz, IH, H(5)eq], 3.79 [d. 
1=12.0 Hz, H(7)eq], 4.00 [d, 1=7.3 Hz, IH, H(2)ax]. 
4.19 [d, 1 = 12.0 Hz, 1H ArCH2], 4.24 [d, 1 = 7.3 Hz. IH. 
H(2)eq], 4.40 [dd, 1 = 12.6, 5.9 Hz, ArCH2], 4.54 [dd, 
J = 12.6, 3.9 Hz, IH, ArCH2], 7.25-7.39 [m, SH, ArH]. 
9.53 [br s, IH, N-"--H]; T3C NMR (DMSO-d6) ppm 
28.26 [t, C(9)], 31.34 [d, C(8)], 31.80 [t, C(l 1)], 37.39 [s, 
C(4a)], 46.36 [q, CH3O], 52.33 [T, C(4)], 54.25 [t, C(7)], 
55.40 [t, C(5)], 56.21 [t, ArCH2], 60.20 [t, ArCH2], 78.00 
[t, C(2)], 93.75 [s, C(8a)], 127. 14, 128.27, 129.09, 129.65, 
130.60, 136.98 [Are]. Analysis calculated for 
C24H30N2N2O2S.2 HCIO4: C, 47. 14; H, 5.27; Cl, 11.59; 
N, 4.58; S, 5.24. Found: C, 47.22; H, 5.14; Cl, I 1.38: N, 
4.44; s, 5.47. 
(77) 
In order to illustrate the useful biological activity of 
the compounds according to the present invention. 
65 sel~cted derivatives were tested using dog models for 
an~1arrhythmic activity. The clinically used drug lido-
came was employed as a basis for comparison. In the 
dog model an infarction was created in a small area of 
5,043,445 
42 41 
the heart and thereafter an electrical pacing was admin-
istered to generate a sustained ventricular tachycardia 
(VT). This irregular bearing pattern of the heart results 
TABLE-continued 
Antiaarhythmic Data for Representative Compounds of the 3, 7-
Diheterabicyclo[3.3. l jnonanes and Derivatives 
in a reduction of the heart's pumping capacity in a man- 5 
ner now accepted as resembling symptoms observed in 
humans during heart attack (see: Scherlag, B. J. et al. 
Am. J. Cardiol. 1983, 51, 207; Bailey, B. B. et al, J. Med. 
Chem., 1984, 27, 759; and U.S. Pat. No. 4,581,361 for 
3 mg/kgc 6 mg/kgd 
Com- Pacing Rate of Rate of Rate of 
pound Rate• MBP0 SVTb MBP SVT MBP SVT 
(77) 390 101 
"Mean Blood Pressure during normal sinus rhythm beforea VT is induced. 
b:sustained Ventricular tachycardia 
330 
further details, said references incorporated herein for 
such purposes). The effects of the selected compounds 
in terms of ability to reduce the rate of the ventricular 
tachycardia or to eliminate the same (i.e., to not allow 
VT to be sustained) is then evaluated and compared to 
the drug lidocaine. The following Table contains the 
data observed as result of the testing. 
TABLE 
Antiaarhythmic Data for Representative Compounds of the 3,7-
Diheterabicvclo[3.3. ljnonanes and Derivatives 
3 mg/kgc 6 mg/kgd 
10 
<3 mg of compound per kg of dog model 
d6 mg of compound per kg of dog model 
«()control before compound is added to dog model 
ftL)Lidocainc 
'MBP before compound is added to dog model 
15 "MBP during sustained VT 
20 
~BP during sustained VT 
,(.\'S)Nonsustained VT 
•Electrically stimupacing rate required to induce an SVT 
••cndo•exo isomer 
From the Table, it is concluded that the compound 
(45) was extremely effective in reducing the ventricular 
tachycardia (as compared to lidocaine) at a concentra-
Com- Pacing Rate of Rate of Rate of tion of only 3 mg/kg. The same was true in compounds 
_p_ou_n_d_R_at_e• __ M_B_P_•_s_v_T_b_M_B_P __ s_v_T __ M_B_P __ s_v_T_ 25 (28), (50), (59**), (71), and (72). In (47), (65), and (66), 
450(C)' 170K 
450(LY 
(45) 450 
(50)" 
330(C) 160K 
(70)" 
(47) 330 
330(C) 160K 
(70)" 
(50) 330 
330(C) 70" 
390(L) 
360(L) 
(66) 360 
(66) 390 
360(C) 90" 
330(L) 
300(L) 
(66) 390 
390(C) 90" 
390(L) 
390(L) 
(65) 390 
(65) 390 
390(C) 102• 
390(L) 
390(L) 
(28) 390 
390(C) 70" 
360(L) 
360(L) 
(71) 390 
360(C) sos 
390(L) 
330(L) 
(72) 360 
(72) 390 
330(C) 70" 
(59 .. ) 330 
(59••) 330 
390(C) 95h 
390(L) 
360(L) 
(77) 390 
450 
330 
330 
270 
390 
390 
390 
390 
330 
330 
(NS) 
375 
1001 330 
240 
85 300 
270(NS) 
95 330(NS) 
300 
99 (NS) 
300 
300 
92 210 
330 
99 330 
360 
85 340 
360 
90 330 
70 300 
No VT 
98 330 
70 
95 
85 
86 
75 
270 
(NS) 
310 
240 
240 
270 
270 
(NS) 
210 
330 
210 
330 
280 
270 
the VT generated in the dog model was virtually elimi-
nated by the compound and a normal sinus rhythm \Vas 
observed. Thus, the generated VT was not sustained in 
the presence of the compound. In contrast, the VT was 
30 sometimes reduced by the presence of lidocaine. but 
was rarely eliminated. Thus, the heterocycles claimed 
in the application appear to have electrocardiology 
properties equal or superior to lidocaine, a clinically 
35 used drug for the treatment of victims of heart attacks. 
40 
This in combination with the possibility that the hetera 
atoms afford the use of a radioactive isotope for imagin-
ing (e.g., the use of 75Se) purposes creates the possibility 
of in vivo analysis simultaneously with therapeutic 
treatment. 
In principle, it is felt that the compositions of the 
present invention can be employed by themselves, in 
combination with each other, or in combination with 
45 other drugs to achieve either individually or in combi-
nation the desired antiarrhythmic properties. It is envi-
sioned that the composition can be utilized and adminis-
tered in a variety of methods including by way of exam-
ple, but not limited thereto, intravenously, orally,. by 
SO suppository, by inhalation, and theHke. Furthermore, it 
is generally felt that the compositions as claimed either 
specifically possess antiarrhythmic activity or generally 
are broadly biologically active or the respective compo-
55 sitions are intermediaries to antiarrhythmic and biologi-
cally active species that are released or created in situ as 
the result of the administration of the drug. 
Having thus described and exemplified the preferred 
embodiments with a certain degree of particularity, it is 
60 to be understood that the invention is not to be limited 
to the embodiments set forth herein for purposes of 
exemplification, but is to be limited only by the scope of 
the attached claims, including a full range of equivalents 
65 to which each element thereof is entitled. 
We claim: 
1. A polyheterotricyclo compound having the formu-
lae: 
where 
Ar is 
43 
Ar O Ar \'~<} 
Ar.,. l J -. Ar 
z 
5,043,445 
44 
5 
10 
15 
-continued 
Z is S, Se, 0, CHR' or NR'; 
X- is CI04-, CJ-, Br-, or I-; 
R is CH3, C2Hs, C3H7 or C4-C9 alkyl; and 
R' is H, CH3, C2Hs, or C(CH3)3. 
2. A polyheterotricyclo compound of claim 1 
wherein Ar is 
-CH,-O 
20 3. A polyheterotricyclo compound of claim 2 where 
Z is Se. · 
4. A polyheterotricyclo compound of claim 2 where 
Z is S. 
5. A polyheterotricyclo compound of claim 3 where 
25 R is CH3. 
6. A polyheterotricyclo compound of claim 4 where 
R is CH3. 
7. A polyheterotricyclo compound of claim 5 \vhere 
x- is CJ04-. 
30 8. A polyheterotricyclo compound of claim 6 where 
X- isCl04-. 
* * * * * 
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